Caenorhabditis elegans as a model to study molecular mechanisms of methylmercury toxicity by Helmcke, Kirsten Jeanne
CAENORHABDITIS ELEGANS AS A MODEL TO STUDY MOLECULAR 
MECHANISMS OF METHYLMERCURY TOXICITY 
 
By 
Kirsten Jeanne Helmcke 
 
Dissertation 
Submitted to the Faculty of the 
Graduate School of Vanderbilt University 
in partial fulfillment of the requirements 
for the degree of 
DOCTOR OF PHILOSOPHY 
in 
Pharmacology 
May, 2010 
Nashville, Tennessee 
 
Approved: 
Professor Michael Aschner 
Professor BethAnn McLaughlin 
Professor Eugenia V. Gurevich 
Professor Ariel Y. Deutch 
Professor David M. Miller, III 
 
ACKNOWLEDGEMENTS 
 
 Many individuals and organizations contributed to and made this work 
possible.  I would like to thank the Vanderbilt Interdisciplinary Graduate Program, 
the Pharmacology Department, and the Training Program in Molecular 
Toxicology (T32 ES007028) for not only providing financial support but also for 
giving me the educational foundation on which I could build my research. Many 
individuals in these departments and programs contributed to my success, I 
would particularly like to thank the Director of Graduate Studies in Pharmacology, 
Joey Barnett, and the Educational Coordinator for Pharmacology, Karen Gieg, for 
their guidance and assistance. 
 My committee of Michael Aschner, BethAnn McLaughlin, Eugenia 
Gurevich, Ariel Deutch, and David Miller has been very helpful in guiding my 
research. As my committee chair, BethAnn provided me thorough meeting 
summaries outlining the necessary steps to further my project amazingly quickly 
after each meeting and was happy to discuss any questions or issues I had. 
While neither Eugenia nor Ariel is a toxicology expert, they both provided 
valuable insights and support. David was extremely accommodating in allowing 
for my development as a C. elegans biologist by providing a number of resources 
including attendance at his group meetings and the assistance of his lab 
members, whom I am grateful to for helping me to develop many of the 
methodologies that I used. 
 ii
 In addition to the Miller lab, the support of many collaborators who 
provided scientific input as well as technical expertise was required for 
completion of this work. Lars Evje in Tore Syversen’s lab performed ICP-MS 
experiments. The Randy Blakely lab provided materials and equipment for 
conducting thrashometer experiments and I was able to conduct these studies 
with the help of Dawn Matthies and Shannon Hardie. Jiyang Cai provided 
materials, equipment, and assistance for HPLC experiments. I am appreciative of 
the time and resources that each one of these individuals put forth to assist me. 
 I am indebted to Michael Aschner for being a fantastic scientist, great 
teacher, and all-around wonderful person. Everyone in the Aschner lab also 
contributed to this work, whether directly or by helping with experiments, 
discussions, or friendship. In particular, I would like to thank the other worm 
researchers, including Catherine Au and George Jiang, who helped to set up the 
system and protocols in the lab, Alexandre Benedetto for helping to build the 
system in the lab, and Daiana Silva Avila, Margaret Adams, and Sudipta 
Chakraborty, for continuing with this work. I am also grateful to Alycia Buford for 
her administrative help in the lab. 
 I also would like to express my gratitude to my friends for helping keeping 
me grounded throughout this process. Finally, I would like to thank my parents 
for their unwavering love and support in all my endeavors and for being 
extraordinary role models. 
 iii
TABLE OF CONTENTS 
 
Page 
ACKNOWLEDGEMENTS......................................................................................ii 
LIST OF TABLES ................................................................................................vii 
LIST OF FIGURES ............................................................................................. viii 
LIST OF ABBREVIATIONS .................................................................................. x 
Chapter 
I. INTRODUCTION ............................................................................................... 1 
          Mercury....................................................................................................... 1 
          Human exposure to mercury ...................................................................... 2 
          Methylmercury ............................................................................................ 4 
               Metabolism and bioaccumulation of MeHg ............................................ 4 
               Neurotoxicological effects of MeHg ....................................................... 5 
          Mechanisms of MeHg action ...................................................................... 7 
               MeHg protective mechanisms ............................................................... 9 
               Glutathione .......................................................................................... 10 
               Metallothioneins................................................................................... 14 
               Hormesis ............................................................................................. 16 
               Heat shock proteins ............................................................................. 18 
               Contributions of GSH, HSPs, and MTs to MeHg toxicity ..................... 19 
           A model system to examine the molecular mechanisms of MeHg toxicity:       
               Caenorhabditis elegans ....................................................................... 20 
               Nervous system................................................................................... 23 
               Toxicological model ............................................................................. 23 
               Tools for studying C. elegans: RNAi .................................................... 25 
               Tools for studying C. elegans: mutagenesis ........................................ 27 
               Tools for studying C. elegans: behavioral analysis.............................. 27 
               Tools for studying C. elegans: neuroanatomy ..................................... 28 
               Metal toxicity testing in C. elegans ...................................................... 29 
               Proteins related to MeHg toxicity in C. elegans ................................... 34 
               The proposed research program: use of C. elegans to assess MeHg      
                    cytotoxicity ...................................................................................... 35 
 
 
 iv
II. CHARACTERIZATION OF THE EFFECTS OF MEHG ON C. ELEGANS ..... 39 
          Summary .................................................................................................. 39 
          Introduction............................................................................................... 40 
          Methods.................................................................................................... 42 
               C. elegans maintenance ...................................................................... 42 
               MeHgCl treatments.............................................................................. 43 
               Lethality ............................................................................................... 43 
               Determination of Hg content ................................................................ 44 
               Lifespan and brood size analysis......................................................... 45 
               Measurement of size and developmental progress ............................. 46 
               Behavioral analysis: Pharyngeal pumping and thrashing rates ........... 46 
               Microscopic observation of neurons .................................................... 47 
               Statistics .............................................................................................. 48 
          Results...................................................................................................... 48 
               C. elegans larvae are sensitive to MeHgCl.......................................... 48 
               Hg accumulates in a dose-dependent manner in animals treated with  
                    MeHgCl........................................................................................... 50 
               MeHgCl does not alter lifespan or brood size of C. elegans ................ 51 
               MeHgCl treatment retards C. elegans larval development .................. 54 
               Pharyngeal pumping decreases following MeHgCl exposure, thrashing  
                    is unaffected ................................................................................... 59 
               Alterations in neuronal morphology were not observed in worms that  
                    survived MeHgCl exposure............................................................. 61 
          Discussion ................................................................................................ 63 
 
III. HORMETIC EFFECT OF MEHG ON C. ELEGANS ...................................... 72 
          Summary .................................................................................................. 72 
          Introduction............................................................................................... 73 
          Materials and Methods ............................................................................. 77 
               C. elegans maintenance and strains.................................................... 77 
               MeHgCl treatments.............................................................................. 78 
               Hg content ........................................................................................... 79 
               Lethality ............................................................................................... 80 
               Measurement of fluorescence intensity ............................................... 80 
               Glutathione quantification .................................................................... 81 
               Statistics .............................................................................................. 82 
          Results...................................................................................................... 83 
               Hg accumulates in live animals following MeHgCl treatment............... 83 
               Increased expression of gst-4, hsp-4, mtl-1 and mtl-2 following MeHgCl  
                    exposure......................................................................................... 83 
               mtl but not gst-4 knockouts display increased sensitivity to MeHgCl... 86 
               MeHgCl induces hormesis in wild-type C. elegans .............................. 88 
               Contribution of gst-4, hsp-4, mtl-1, and mtl-2 to hormesis ................... 88 
               MeHgCl induces alterations in glutathione levels ................................ 93 
 v
          Discussion ................................................................................................ 93 
 
IV. CONCLUSION ............................................................................................ 102 
          Summary ................................................................................................ 102 
          Future Directions .................................................................................... 109 
          Implications............................................................................................. 114 
 
REFERENCES................................................................................................. 115 
 vi
LIST OF TABLES 
 
Table Page 
1. MeHgCl developmentally delays C. elegans............................................ 58 
 vii
LIST OF FIGURES 
 
Figure Page 
1. Model of mechanisms of MeHg toxicity...................................... 12 and 104 
2. Dose–response curve of lethality of MeHgCl to C. elegans ..................... 49 
3. Hg content in C. elegans following MeHgCl exposure. ............................ 52 
4. Lifespan is unaltered following MeHgCl in C. elegans ............................. 53 
5. C. elegans brood size is unaltered following MeHgCl exposure .............. 55 
6. Body length of C. elegans was shorter following treatment with MeHgCl 56 
7. C. elegans larvae were developmentally delayed following exposure to 
MeHgCl.................................................................................................... 57 
 
8. Pharyngeal pumping rates of C. elegans decrease following MeHgCl 
exposure .................................................................................................. 60 
 
9. Thrashing rate of animals was not altered in a MeHgCl-dose-dependent 
manner..................................................................................................... 62 
 
10. Dopaminergic C. elegans neurons following MeHgCl insult..................... 64 
 
11. GABAergic C. elegans neurons following MeHgCl insult ......................... 65 
 
12. Glutathione cycle ..................................................................................... 75 
 
13. Concentration of Hg in live animals following MeHgCl exposure ............. 84 
 
14. Treatment of gst-4::GFP, hsp-4::GFP, mtl-1::GFP, and mtl-2::GFP C. 
elegans with MeHgCl induces increases in GFP fluorescence ................ 85 
 
15. Treatment of knockout animals reveals increased sensitivity in mtl null 
animals following chronic exposure to MeHgCl ....................................... 87 
 
16. Pretreatment with MeHgCl renders C. elegans more resistant to a 
subsequent exposure to the toxicant ....................................................... 89 
 
17. Fluorescence of gst-4::GFP, hsp-4::GFP, mtl-1::GFP, and mtl-2::GFP 
strains following hormesis treatments...................................................... 90 
 viii
 
18. Re-analysis of mtl-1::GFP, mtl-2::GFP, hsp-4::GFP, and gst-4::GFP 
fluorescence following hormesis treatments ............................................ 92 
 
19. Glutathione levels in C. elegans treated with MeHgCl ............................. 94 
 ix
LIST OF ABBREVIATIONS 
 
Abbreviation Meaning 
ADHD .......................................................... attention deficit hyperactivity disorder 
ADP ................................................................................... adenosine diphosphate 
Al .............................................................................................................aluminum 
ANOVA....................................................................................analysis of variance 
As ................................................................................................................arsenic 
ATP ................................................................................... adenosine triphosphate 
Ba ................................................................................................................ barium 
BCA ............................................................................................ bicinchoninic acid 
BDNF...................................................................brain-derived neurotrophic factor 
bFGF .........................................................................basic fibroblast growth factor 
C................................................................................................................ cysteine 
Ca............................................................................................................... calcium 
Cd.............................................................................................................cadmium 
Co..................................................................................................................cobalt 
Cr.............................................................................................................chromium 
CREB ..................................................................cAMP response element binding 
C. elegans .........................................................................Caenorhabditis elegans 
CGC .................................................................... Caenorhabditis Genetics Center 
Cu................................................................................................................ copper 
Cys ............................................................................................................ cystiene 
 x
dH2O .................................................................................................distilled water 
DNA...................................................................................... deoxyribonucleic acid 
dsRNA .................................................................................. double stranded RNA 
EPA ................................................................... Environmental Protection Agency 
EtHg ...................................................................................................ethylmercury 
E. coli............................................................................................. Escherichia coli 
FOXO ............................................................................................. forkhead box O 
γ-GluCys..........................................................................gamma-glutamylcysteine 
GABA ...................................................................................... γ-aminobutyric acid 
GFP .................................................................................green fluorescent protein 
GPx .................................................................................... glutathione peroxidase 
GSH......................................................................................... reduced glutathione 
GS-MeHg .......................................................glutathione-methylmercury complex 
GSSG ......................................................................................oxidized glutathione 
GST .................................................................................glutathione s-transferase 
GR........................................................................................ glutathione reductase 
GRP78................................................................... 78-kDa glucose-related protein 
HNO3 ....................................................................................................... nitric acid 
HPLC...................................................... high performance liquid chromatography 
HR-ICP-MS....... High Resolution Inductively Coupled Plasma Mass Spectrometry 
HSF ............................................................................................. heat shock factor 
HSP ........................................................................................... heat shock protein 
Hg.............................................................................................................. mercury 
 xi
HgCl2 ........................................................................................... mercuric chloride 
ICP-MS........................................ Inductively Coupled Plasma-Mass Specrometry 
Keap1 .............................................................kelch-like ECH-associated protein 1 
KOH....................................................................................... potassium hydroxide 
LAT-1.............................................................. large neutral amino acid transporter 
LDX ....................................................................... lethal dose for X% of organisms 
L1 .................................................................................................. first larval stage 
L2 ............................................................................................ second larval stage 
L3 ................................................................................................. third larval stage 
L4 ............................................................................................... fourth larval stage 
MeHg...............................................................................................methylmercury 
MeHgCl ............................................................................. methylmercury chloride 
μg .......................................................................................................... microgram 
mg ............................................................................................................milligram 
μL .............................................................................................................microliter 
mL .............................................................................................................milliliters 
mM .......................................................................................................... millimolar 
mol/L.................................................................................................moles per liter 
MT .................................................................................................. metallothionein 
MT-MeHg ................................................ metallothionein-methylmercury complex 
M9 ...............................................................................................C. elegans buffer 
NFĸB ......................nuclear factor kappa-light-chain-enhancer of activated B cells 
ng ........................................................................................................... nanogram 
 xii
 xiii
NGM ..............................................................................nematode growth medium 
Nrf2........................................................ nuclear factor-erythroid 2-related factor 2 
N2........................................................................................... wild type C. elegans 
OP50 ...................................................................................................E. coli strain 
Pb .................................................................................................................... lead 
ppm ............................................................................................... parts per million 
RNA................................................................................................ribonucleic acid 
RNAi ............................................................................................RNA interference 
ROS.................................................................................. reactive oxygen species 
U................................................................................................................ uranium 
VEGF................................................................. vascular endothelial growth factor 
WT............................................................................................................ wild type 
Zn .....................................................................................................................zinc 
CHAPTER I 
 
INTRODUCTION 
 
Mercury 
 Mercury (Hg) is a heavy, silvery white, transition metal that exists in a 
liquid state at room temperature. Hg is found in different oxidation states, 
including the zero oxidation state (Hg0), the first oxidation state as mercurous 
mercury (Hg1+), and the second oxidation state as mercuric mercury (Hg2+). Hg0 
is present in the metallic form or as vapor and, upon oxidation, is the source for 
the other forms in higher oxidation states. Electron loss yields Hg1+, which is 
commonly found as calomel or mercurous chloride (as Hg22+). Hg2+ is a major 
component of most organic and inorganic Hg-containing compounds, including 
methylmercury (MeHg) and ethylmercury (EtHg). Hg is found in a number of 
commonly used compounds, is released upon metabolism of organic Hg 
compounds, and is present in inhaled vapor, making an understanding of the 
effects of Hg on biological systems essential, particularly given that Hg has been 
identified as an important toxicant (Clarkson and Magos, 2006). 
 Hg, typically present in the liquid and vapor forms as Hg0, undergoes the 
phenomenon of global cycling. The vapor is released from natural sources, such 
as volcanoes, soil, and water surfaces; and from man-made sources, such as 
coal-burning power stations and incinerators. The Hg0 vapor can remain in the 
atmosphere for an extended period of time, allowing for vast dispersal around the 
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globe, during which it can be oxidized to Hg2+. Due to its higher water solubility, 
Hg2+ accumulates in atmospheric moisture and falls to the earth as precipitation. 
Once it reaches the earth, Hg2+ can be reduced back to Hg0 and re-enter the 
atmosphere or be absorbed by vegetation. Alternatively, the Hg2+ that falls to 
earth can reach aquatic environments and come in contact with microorganisms, 
specifically sulfate-reducing bacteria that convert inorganic Hg to MeHg in a 
detoxification reaction. MeHg then travels up the food chain when fish that eat 
these bacteria are in turn eaten by larger fish (Fitzgerald and Clarkson, 1991; 
Mason et al., 2005). During this process, bioaccumulation occurs to such an 
extent that sharks and carnivorous sea mammals end up having some of the 
highest levels of MeHg (4ppm), equivalent to a million-fold bioaccumulation 
(Clarkson and Magos, 2006). 
 
Human exposure to mercury 
 Humans are exposed to Hg through three major routes: Hg vapor emitted 
from amalgam dental fillings, EtHg which is absorbed when it is used as a 
preservative in vaccines, and MeHg which is absorbed from seafood. Average 
daily intake of Hg has been measured at approximately 6.6 µg. Nearly 0.6 µg of 
this comes from MeHg in fish sources and approximately 4 µg comes from 
inorganic sources, most in the form of Hg0 vapor inhalation (WHO, 1990) from 
dental and occupational sources while atmospheric levels are negligible 
(Fitzgerald and Clarkson, 1991). 
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 Depending on the form of exposure, Hg can produce effects in the body 
which involve various organ systems. Acrodynia, or painful extremities, is 
attributed to exposure to the Hg2+ used in agents such as laxatives and teething 
powders. Symptoms of Hg0 inhalation through dental or occupational exposure 
include tremor, psychological disturbances, and renal toxicity (WHO, 1991; 
Clarkson and Magos, 2006). Due to the dissociation of Hg atoms, exposure to 
organic forms of Hg can result in symptoms similar to those observed with Hg0 
vapor exposure (WHO, 1991; Clarkson and Magos, 2006). Hg2+ is extremely 
toxic, with extensive exposure leading to renal failure as well as stomatitis and 
gastroenteritis, and even autoimmune disease (Pollard and Hultman, 1997; 
Clarkson and Magos, 2006).  
 The effects of Hg vapor emitted from dental fillings and EtHg found in 
vaccines on the health of organisms have been debated. While some research 
has found deleterious effects on the nervous system, these reports are countered 
by other studies finding no association between these toxicants and diseases. 
For example, Hg vapor has been associated with the induction of 
neurodegenerative diseases such as Alzheimer’s Disease (Mutter et al., 2004) 
and EtHg has been blamed for triggering autism (Geier and Geier, 2006). 
However, both of these causative relationships have come under scrutiny 
(Factor-Litvak et al., 2003; Parker et al., 2004; Thompson et al., 2007). The use 
of Hg amalgams as dental fillings has fallen out of favor due to environmental 
concerns regarding Hg disposal and EtHg has been removed from most vaccines 
due to health concerns; therefore, these routes of Hg exposure are being 
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reduced. Conversely, in spite of the fact that the destructive properties of MeHg 
have been widely reported and accepted, consumption of this toxicant in seafood 
persists. 
  
Methylmercury 
Metabolism and bioaccumulation of MeHg 
 Organic Hg compounds are well-characterized with regard to distribution 
in the body and metabolism. The environmental protection agency (EPA) has 
established a reference dose of 0.1 μg/kg body weight/day, corresponding to a 
level of approximately 5.8 μg/L Hg in the blood or 1.0 μg/g in hair (EPA, 2001). 
Upon ingestion MeHg is well absorbed through the gastrointestinal tract. In the 
liver, MeHg can form a complex with reduced glutathione to be excreted in bile, 
which can be reabsorbed by the small intestine once broken down or can be 
metabolized by intestinal microflora to produce Hg2+. Fecal excretion is the main 
route of elimination (Clarkson et al., 1981; Patrick, 2002; Clarkson and Magos, 
2006).  
 MeHg has high affinity for thiol groups, a property thought to contribute to 
its toxicity. This leads to the ability of MeHg to bind to proteins via their cysteine 
side chains. The MeHg-cysteine complex molecularly mimics methionine, 
allowing for its passage through the blood-brain and placental barriers and into 
cells via the large amino acid transporter, LAT1 (Kerper et al., 1992; Simmons-
Willis et al., 2002; Yin et al., 2008). MeHg accumulates in the brain at high levels, 
as much as five times the concentrations observed in blood (WHO, 1990). 
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Conversion to inorganic Hg occurs within the brain, and long-term studies have 
shown that years after exposure to MeHg, Hg accumulated in the brain in the 
inorganic form (Simmons-Willis et al., 2002; Clarkson and Magos, 2006). Due to 
its passage through the blood-brain and placental barriers, MeHg in the brain of a 
newborn can reach levels as high as five times those seen in the mother 
(Cernichiari et al., 1995; Clarkson, 2002; Clarkson and Magos, 2006).  
 
Neurotoxicological effects of MeHg 
 The neurotoxicological effects of MeHg were revealed after unfortunate 
high-dose poisoning events, one due to local pollution of Minamata Bay in Japan 
and the subsequent high concentrations of MeHg in fish, and another event due 
to consumption of grain treated with a MeHg-fungicide in Iraq (Clarkson, 2002). 
Additional investigations of the neurotoxicity of MeHg were conducted in the 
seafood-consuming populations in the Seychelles (Davidson et al., 1998; Myers 
et al., 2009) and Faroe Islands (Grandjean et al., 1997; Debes et al., 2006).  
 High levels of MeHg exposure such as those encountered in the 
Minamata and Iraqi poisonings were manifested in a number of ways including 
sensory impairments, paralysis, hyperactive reflexes, cerebral palsy, and 
impaired mental development (National Research Council, 2000). In Minamata 
Bay, MeHg was released directly into the water by a chemical plant, leading to 
high MeHg content in marine samples (5.61-35.7 ppm). Consumption of these 
products led to Minamata disease, first discovered in 1956. MeHg levels in the 
2252 officially recognized patients had hair MeHg levels as high as 705 ppm 
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(Harada, 1995) and umbilical cord samples of Minimata disease patients 
contained 1.60 ppm MeHg. In 1971-72 a MeHg poisoning event occurred in Iraq 
where approximately 6530 individuals were admitted to the hospital after eating 
grain treated with a MeHg fungicide. Levels of 240-480 ng Hg/mL blood were 
associated with increases in complaints of paresthesia (Clarkson et al., 1976).  
 The neurotoxicological effects of MeHg on humans vary based on age at 
the time of exposure. Adults exposed to MeHg experience focal lesions, such as 
loss of cerebellar granular cells and occipital lobe damage (Clarkson and Magos, 
2006), whereas younger individuals experience global alterations to the brain, 
including microcephaly and inhibition of neuronal migration, leading to distortion 
of cortical layers, cerebellar abnormalities, alterations in glial cells (such as 
decreased amino acid uptake (Aschner et al., 1993)), and alterations in 
neurotransmitter systems. 
 Although some researchers observed delays in the achievement of 
developmental milestones upon low-level chronic MeHg exposure, a number of 
epidemiological studies conducted in populations exposed to MeHg through diet 
have been inconclusive as to the clinical effect of low-dose chronic exposure to 
MeHg through seafood consumption (Clarkson and Magos, 2006).   
 Two large studies have been conducted, one in the Seychelles Islands 
and one in the Faroe Islands (Grandjean et al., 1997; Davidson et al., 1998; 
Debes et al., 2006; Myers et al., 2009). In the Seychelles Islands, endpoints 
measured at 66 months largely revealed a positive association between MeHg 
exposure and developmental outcomes, revealed by the McCarthy Scales of 
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Children's Abilities-General Cognitive Index score, the Preschool Language 
Scale-Total Score, and the Woodcock-Johnson Applied Problems test (Davidson 
et al., 1998). At 107 months, negative associations between MeHg exposure and 
performance were revealed by a decline in performance on Connor's Teacher 
Rating Scale ADHD Index, Wechsler Intelligence Scale for Children-Revised, the 
Grooved Pegboard with the non-dominant hand, and the Connor's Continuous 
Performance Task Risk Taking (Myers et al., 2009). From the study in the Faroe 
Islands it was concluded that postnatal MeHg exposure produced no significant 
adverse effects when children were tested at 14 years of age (Debes et al., 
2006). However, endpoints tested at 7 years of age did reveal an adverse 
association between MeHg exposure and performance on Finger Tapping with 
both hands and the Reaction Time from the Continuous Performance Test 
(Grandjean et al., 1997).  
 These differences have been attributed to differences in measurement 
techniques, the extent of MeHg exposure, and other confounding variables. 
Additionally, the health benefits of seafood consumption likely confound these 
results and lead to questions surrounding the costs and benefits of the 
consumption of seafood. 
 
Mechanisms of MeHg action 
 While several neurological targets of MeHg have been identified, the 
specific mechanisms of cellular dysfunction are unknown. Microarray analyses 
have revealed many genes are altered upon exposure to MeHg and suggest an 
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effect of MeHg on transcription or RNA stability (McElwee et al., 2007). A diverse 
range of potential targets, such as factors involved in cell cycle regulation, 
apoptosis, immune functioning, and G-protein signal transduction have been 
elucidated (Ayensu and Tchounwou, 2006). Some of the known effects of MeHg 
include an inhibition of DNA, RNA, and protein synthesis (Gruenwedel and 
Cruikshank, 1979); disruption of microtubules leading to mitotic alterations 
(Rodier et al., 1984); and increases in intracellular calcium (Ca2+) leading to 
alterations in neurotransmitter function, excitotoxicity, and oxidative stress (Sirois 
and Atchison, 1996). Disruption of Ca2+ by depolarization of the presynaptic 
membrane leads to alterations in dopamine, γ-aminobutyric acid (GABA), 
glycine, choline, and acetylcholine signaling (Dwivedi et al., 1980; O'Kusky and 
McGeer, 1989; Levesque et al., 1992; Aschner, 2000; Bemis and Seegal, 2000; 
Atchison, 2005; Kobayashi et al., 2005; Basu et al., 2006; Herden et al., 2008; 
Sunol et al., 2008; Dreiem et al., 2009). A common theme of MeHg toxicity is 
targeted dysfunction of thiol groups, with its affinity for these groups being ten 
orders of magnitude higher than the affinity for oxygen-, chloride-, or nitrogen-
containing ligands (West et al., 2008). By binding to protein sulfhydryl groups, 
MeHg can indirectly alter the structure of DNA and RNA (Gruenwedel and Lu, 
1970) and induce alterations in anabolic processes, enzyme function, and protein 
synthesis (Syversen, 1982; Myers et al., 2009). For instance, MeHg interaction 
with microtubules is thought to be due to its ability to bind sulfhydryl groups 
(Vogel et al., 1985). The inhibition of tubulin polymerization (Rodier et al., 1984; 
Graff et al., 1993) and microtubular fragmentation (Castoldi et al., 2000) have 
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been shown to play a role in the toxicity of MeHg by disrupting various processes 
including mitosis and neuronal migration (Myers et al., 2009).  
 On a molecular level, MeHg has been shown to be able to activate 
Nuclear factor-erythroid 2-related factor 2 (Nrf2). Nrf2 is able to activate the 
antioxidant response element/electrophile responsive element (ARE/EpRE) upon 
its release from Kelch-like ECH-associated protein 1 (Keap1) by binding to the 
ARE in the promoter region and activating gene expression (Itoh et al., 1997). 
These induced genes include antioxidant proteins, phase II xenobiotic-
metabolizing enzymes and phase III transporters, which allow for metabolism of 
xenobiotics. The activation of Nrf2 occurs via an interaction of MeHg with thiol 
groups on Keap1 which results in the release of Nrf2 from Keap1 (Toyama et al., 
2007).Additionally, increased expression of Nrf2 diminshes the toxicity of MeHg 
(Rand et al., 2009; Wang et al., 2009). 
 
MeHg protective mechanisms 
 Studies have investigated the detoxification and removal of MeHg from 
biological systems, showing that a number of proteins are involved in the 
detoxification and excretion of MeHg; these include glutathione (GSH), heat 
shock proteins (HSPs), and metallothioneins (MTs). MeHg is also known to 
induce generation of reactive oxygen species (ROS) through alterations in 
mitochondrial respiration and the electron transport chain (Verity et al., 1975; Yee 
and Choi, 1996) and the generation of hydroxyl radicals from the breakdown of 
hydrogen peroxide (Patrick, 2002). ROS can have a number of harmful effects 
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including DNA damage, lipid peroxidation, and amino acid oxidation. Anatomical 
brain regions with increased MeHg-induced ROS generation show increased 
damage, with toxic effects of MeHg mirroring the oxygen demands for the given 
cell type (Sarafian and Verity, 1991; Bondy, 1994; Yee and Choi, 1996). Although 
GSH, HSPs, and MTs have been implicated in resistance to MeHg toxicity, 
researchers have not fully elucidated their precise role in detoxification. However, 
many of their described roles involve protection through activation by or defense 
from ROS and the ability of these proteins to bind MeHg due to their Cys content. 
The potential mechanisms of protection afforded by these three systems are 
described in the following sections. 
 
Glutathione 
GSH is the major antioxidant within cells. It is a tripeptide consisting of 
glutamic acid, cysteine, and glycine and can exist in the reduced (GSH) or the 
oxidized (GSSG) state. It is formed when gamma glutamylcysteine (γ-GluCys) 
synthetase catalyzes the production of γ-GluCys from glutamic acid and cysteine 
(the rate-limiting component of the synthesis of GSH). GSH synthetase then 
catalyzes the production of GSH by combining γ-GluCys and glycine. Glutathione 
peroxidase (GPx) catalyzes the oxidation of GSH to GSSG in the presence of 
ROS. GSSG can then be converted back into GSH via glutathione reductase 
(GR) and the conversion of NADPH to NADP+ (Filomeni et al., 2005). 
Alternatively, glutathione s-transferases (GSTs) can catalyze the conversion of 
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GSH to GS-, which can bind to various xenobiotics to facilitate excretion from the 
body (Hirata and Takahashi, 1981).  
 GSH has been shown to play a large part in MeHg toxicity. MeHg will 
readily bind to sulfhydryl groups. Since GSH is typically the sulfhydryl-containing 
compound in cells with the highest concentration, MeHg easily binds, forming a 
GS-MeHg complex. The binding of GSH to MeHg has two major effects. Firstly, 
binding the toxicant to GSH prevents it from damaging other proteins and 
tissues. Secondly, the GS-MeHg complex is excreted from the organism, both in 
bile (approximately 90% of MeHg excretion) and in urine (approximately 10% of 
MeHg excretion) and its existence in this form facilitates its excretion from the 
body (Patrick, 2002) (Figure 1A). The complex is also important in transport 
throughout the organism, particularly within the nervous system. Endothelial cells 
forming the blood-brain barrier excrete MeHg as a complex with GSH. 
Astrocytes, the first line of defense from toxicants in the brain (Tiffany-Castiglion 
and Qian, 2001) and a major depot for MeHg accumulation (Aschner et al., 
1990), also excrete the GS-MeHg complex. The addition of glutathione, 
glutathione stimulators, or glutathione precursors enhances this excretion and 
cell lines expressing five times the normal level of GSH do not readily 
accumulate MeHg and are resistant to its toxic effects (Patrick, 2002). 
In addition to sequestering and eliminating the toxicant, GSH also plays a well-
established role in the elimination of ROS (Figure 1A). GSH can react directly 
with radicals or, through the action of GPx, GSH can act as an electron donor to 
react with ROS, such as hydrogen peroxide, to form GSSG and water  
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Figure 1. Model of the molecular mechanisms of MeHg toxicity. MeHg induces 
alterations in the cell by generating ROS and binding directly to Cys groups on 
proteins. These induce a number of downstream effects, including induction of 
HSPs to induce degradation of damaged proteins, MTs to bind free MeHg and 
reduce ROS, and GSH to reverse ROS damage and bind directly to MeHg for 
excretion (A). In L1 animals treated acutely with MeHg, MTs, gst-4, and GSH are 
all upregulated, assisting with MeHg detoxification (B). In L4 animals treated 
chronically with MeHg, levels of hsp-4, gst-4, and GSSG are increased, and GSH 
is depleted (C). In preconditioning, gst-4 is increased. Due to the increase in gst-
4, we suspect alterations in the GSH system, but these have not been assessed 
(D). 
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(Fonnum and Lock, 2004). Maintenance of GSH levels following MeHg exposure 
protects cells from oxidative injury (Kaur et al., 2006). However, the excretion of 
MeHg in a complex with GSH causes levels of the antioxidant to decrease, 
thereby rendering cells vulnerable to damage induced by ROS (Fonnum and 
Lock, 2004). The excretion of the GS-MeHg complex inducing depletion in GSH 
can be further amplified by the ability of MeHg to block the uptake of cystiene 
and thus inhibit new GSH synthesis (Allen et al., 2001). Together the decrease in 
GSH generation and increases in excretion have been shown to cause significant 
decreases in GSH in a mouse model of MeHg toxicity, with GSH levels being 
significantly lower (at post natal day 11 control animals contained approximately 
3.8 nmol/mg protein while animals treated with 1, 3, or 10 mg/L contained 
approximately 3, 2.6, or 2.4 nmol/mg protein, respectively). Other contributors to 
the glutathione system were also significantly altered, with significant decreases 
in GPx and GR also being observed (Stringari et al., 2008). 
 Due to the extensive research with GSH and its role in MeHg toxicity both 
by its direct conjugation with the toxicant for elimination and its protection from 
ROS generated by the toxicant (Figure 1A), we hypothesized that this system, 
along with others such as MTs, which also play a role in direct detoxification by 
binding Cys and play an antioxidant role, would be valuable targets to study 
further.
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Metallothioneins 
MTs are small, cysteine-rich metal binding proteins that are involved in 
metal detoxification and homeostasis and can protect cells from oxidative stress 
through this role and their role as antioxidants (Maret, 2008). Additionally, MTs 
can be involved in metal metabolism, cellular repair, regulation of gene 
expression, and are the source of Zn for enzymes (West et al., 2008). Four MTs 
(MT-1, MT-II, MT-III, and MT-IV) exist in mammals, and two of these, MT-I and 
MT-II, have been best-characterized for their protection of the brain although they 
are ubiquitously expressed in all tissues (Penkowa, 2006). MT expression has 
been shown to increase upon exposure not only to various metals but also upon 
exposure to nonmetallic compounds (Sato and Bremner, 1993). Much like GSH, 
MTs are able to detoxify MeHg through binding and sequestering the toxicant 
and act as antioxidants to relieve the damage caused by ROS (Figure 1A). 
Due to their high cysteine content, MTs have a high affinity for MeHg, 
resulting in the formation of a MT-MeHg complex that renders MeHg unable to 
damage other cellular targets. The ability of inorganic Hg to induce expression of 
MTs has been well-established (West et al., 2008) and in some studies, MeHg 
has been shown to induce expression of MTs (Rising et al., 1995; Tsui and 
Wang, 2005). However, a number of other studies have failed to establish a link 
between MT induction and MeHg exposure (Kramer et al., 1996a; Kramer et al., 
1996b; Yasutake et al., 1998; Gonzalez et al., 2005). Although whether MeHg is 
able to induce expression of MTs is debated, the involvement of MTs in MeHg 
toxicity has been firmly established. For example, MeHg induces alterations in 
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behavior of MT-null animals (Yoshida et al., 2008). Overexpression of MTs in 
primary rat astrocytes and astrocytoma cells can attenuate the toxicity of MeHg 
(Yao et al., 1999; West et al., 2008), induction of MTs by other metals decreases 
sensitivity to MeHg (Aschner et al., 1998), and expression of MTs in MT-null cell 
lines affords protection against MeHg (Yao et al., 2000).  
MTs, which are known antioxidants (Maret, 2008), are free radical 
scavengers that have the ability to scavenge a variety of radicals including 
superoxide, hydroxyl, and organic radicals. MT-1 and MT-2 have been shown to 
be  induced in response to oxidative stress (Bauman et al., 1991; Sato and 
Bremner, 1993; Andrews, 2000) and MeHg exposure (Rising et al., 1995). Zn, 
which often binds to the Cys groups on MTs, can be oxidized by ROS, which 
causes the release of Zn from MTs (Maret and Vallee, 1998; Krezel and Maret, 
2007; Maret, 2008). Cellular systems lacking MTs have been shown to have a 
hypersensitivity to ROS (Lazo et al., 1995) and levels of lipid peroxidation, 
protein nitrosylation, and DNA oxidation are increased in the brains of animals 
lacking MTs (Penkowa, 2006). Importantly, due to the ability of ROS to act as an 
intracellular messenger, the scavenging ability of MTs may be related to cellular 
signaling (Sato and Kondoh, 2002). Additionally, MTs have been indicated as 
contributors to the hormetic response, or the ability of a stressor to precondition 
the animal and blunt the effect of a subsequent stressor (Damelin et al., 2000). 
The involvement of MTs in MeHg toxicity and in hormesis hinted that this toxicant 
might be able to induce a hormetic effect. The ability of MeHg to induce hormesis 
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would also indicate that other proteins, such as HSPs, are involved in its 
detoxification. 
 
Hormesis 
 Hormesis, also known as preconditioning or an adaptive stress response, 
is a process whereby a sublethal stressor renders an organism more resistant to 
subsequent injury. This has been demonstrated in a number of models ranging 
from cell cultures to humans under a variety of conditions, including lifestyle 
factors such as exercise (Kojda and Hambrecht, 2005; Gomez-Pinilla, 2008), 
dietary energy restriction (Masoro, 2005; Martin et al., 2006) phytochemicals 
(Mattson, 2008a), or cognitive stimulation (Scarmeas and Stern, 2003); 
environmental exposure to toxicants (Damelin et al., 2000; Calabrese, 2005), 
radiation (Upton, 2001), or temperature (Li et al., 2002); and intrinsic factors such 
as ischemia (Yellon and Downey, 2003), endocrine status, or neurotransmitters 
(Marini et al., 2007; Mattson, 2008b). This process has been necessary to allow 
organisms to adapt to changing environmental conditions (Mattson, 2008b). 
However, the therapeutic use of hormesis is extremely controversial due to a 
number of concerns including the generalizability of the phenomenon across 
conditions, the difficulty of ensuring exposure at a hormetic dose, and ethical 
considerations of exposing individuals to known pathogens (Elliott, 2008). 
 Many of the specific mechanisms of action of hormesis are still unknown. 
While hormesis typically refers to exogenous agents, it can be a part of normal 
physiological functioning, such as the ability of glutamate to cause energetic and 
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oxidative stress at low levels which can activate hormetic pathways and render a 
cell resistant to more severe stress, while a higher exposure to glutamate would 
result in excitotoxicity (Mattson, 2003; Marini et al., 2007). Additionally, exposure 
to one stressor can often offer protection from exposure to another, resulting in 
cross-modal protective effects of exposure to low doses of these agents. 
Exposure to these stressors and agents cause stress and signaling events that 
can involve free radicals, ion fluxes, energy depletion, receptors, kinases, 
phosphatases, deacetylases, and transcription factors such as Nrf2 (Lee and 
Surh, 2005), FOXOs (Frescas et al., 2005), CREB, and NF-ĸB (Carlezon et al., 
2005; Mattson and Meffert, 2006). Downstream of these, antioxidants such as 
superoxide dismutases, catalase, glutathione, and glutathione peroxidase; 
protein chaperones such as HSP70 and GRP78; growth factors such as BDNF, 
VEGF, and bFGF; and other effectors such as mitochondrial proteins and 
calcium-regulating proteins can promote the hormetic response (Mattson, 
2008b).  
 Relating to MeHg exposure, HSPs of the HSP70 family and MTs were 
upregulated following exposure of cells to various heavy metals (Damelin et al., 
2000). Additionally, hormetic mechanisms have been implicated as a possible 
explanation of latency observed in cases of MeHg poisoning (Burbacher et al., 
1990). The involvement of HSPs in the hormetic response and their ability to 
potentially protect an animal from a MeHg insult led to the further investigation of 
these proteins. 
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Heat Shock Proteins 
Under normal conditions, HSPs function as molecular chaperones, 
assisting with protein folding, directing proteins to proper organelles, assembly 
and disassembly of protein complexes, and inhibition of aggregation. Upon 
stress, for example in the presence of MeHg (Sacco et al., 1997), these proteins 
function to assist in the refolding and repair of denatured proteins and can 
facilitate new protein synthesis (Hubbard and Sander, 1991) (Figure 1A). HSPs, 
particularly members of the HSP70 family, have been shown to be involved in 
hormesis. HSP70s are ATP-binding proteins; however, upon binding hydrophobic 
residues, HSP70’s ATPase function is stimulated. When ATP is converted to 
ADP, HSP70 binds peptides to render them inactive and to prevent them from 
aggregating. Since oxidative stress can cause a reduction in cellular ATP levels 
due to the sensitivity of mitochondria to ROS (Lenaz, 1998), HSP70’s ability to 
release ADP to bind ATP is hampered. This results in continued prevention of 
aggregation of damaged proteins (Mayer and Bukau, 2005). In cellular systems 
and in Drosophilia melanogaster, researchers have shown that HSP70 plays a 
role in hormesis. In cellular systems, induction of HSP70s upon stressors has 
been shown (Verbeke et al., 2001) and overexpression of HSP70s has been 
shown to induce protection to stressors (Amin et al., 1996; Plumier et al., 1997). 
In Drosophilia, low-level heat stress, shown to induce HSP70, produced lifespan 
extension (Hercus et al., 2003) and strains carrying an increase in copies of 
hsp70 genes displayed an increase in survival, which increased upon exposure 
to heat (Tatar et al., 1997). 
 18
Due to the demonstrated and hypothesized involvement of GSH, MTs, 
and HSPs, we further explored these proteins relating to MeHg toxicity and how 
they interacted with each other to protect the animal from the toxicant. 
 
Contributions of GSH, HSPs, and MTs to MeHg toxicity 
 Systems involving GSH, HSPs, and MTs have been shown to act in 
harmony to detoxify and excrete MeHg (Figure 1A). Upon MeHg entering a cell, a 
number of processes can be activated. The two major mechanisms through 
which MeHg wreaks havoc on a cell are MeHg binding directly to sulfhydryl 
groups on proteins, and the generation of ROS. Both of these processes can 
induce the activation of HSPs, which can assist to either repair or degrade the 
damaged proteins (Hubbard and Sander, 1991). MeHg can also induce the 
expression of MT-1 and MT-2 (Rising et al., 1995), which in turn bind to and 
sequester MeHg and scavenge free radicals generated by MeHg. The GSH 
system has also been shown to play a role in MeHg toxicity through various 
pathways. Through the cycling of GSH with GSSG, GSH can reduce oxidized 
proteins to repair ROS damage, but it can also directly bind to MeHg due to its 
high cysteine content with the assistance of GSTs (Fonnum and Lock, 2004). As 
a complex with MeHg, GSH is eliminated from the system (Patrick, 2002). 
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A model system to examine the molecular mechanisms of MeHg toxicity: 
Caenorhabditis elegans 
 The task of fully elucidating mechanisms of MeHg toxicity has proven 
difficult due to the complexities of mammalian models and the inability of cell 
systems to demonstrate characteristics of an intact organism. Therefore, a model 
system lacking many of the complexities of mammalian systems and having 
some of the advantages of a cellular system while retaining the advantages of an 
intact organism would be highly beneficial. We used the model organism, 
Caenorhabditis elegans, to overcome these barriers. The simplicity of the C. 
elegans nervous system allows for the assessment of all 302 neurons within the 
system while retaining them within a single living organism. This organism has 
high homology with mammalian systems, and contains many of the proteins 
known to be involved in MeHg toxicity, including HSPs, GSH, and MTs. 
C. elegans is a free-living, soil nematode naturally occurring in temperate 
climates (Hope, 1999). C. elegans has been used as a valuable biological model 
ever since Sydney Brenner’s Nobel Prize-winning investigations used the 
nematode to perform genetic screens for the purpose of unveiling mutations that 
alter its movement (Brenner, 1974). Brenner (Brenner, 1974) demonstrated the 
usefulness of C. elegans as a model system for genetic analysis. Since then, C. 
elegans has been extensively used, with researchers citing its small size, 
transparency, rapid generation time, short lifespan, simple and measurable 
behavior, extensive biological characterization, and genetic tractability due to the 
high degree of conservation of gene sequence as advantages for its use (Hope, 
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1999). These advantages allow C. elegans the unique benefit of being used as 
an in vivo system while maintaining many beneficial characteristics of an in vitro 
system.  
The physical features of C. elegans make it a particularly attractive 
biological model. With adult worms being approximately 1 mm in length, a large 
number of worms can be grown in a very small space, most often on agar plates 
containing Escherichia coli (E. coli), which C. elegans consume as food (Brenner, 
1974). C. elegans are relatively easy and inexpensive to maintain and their 
transparency allows for the observation of cells and features within the entire 
organism without the need to kill or dissect the organism (Hope, 1999; 
WormAtlas, 2002-2009). 
A number of features associated with the C. elegans life-cycle and 
behavior make research using these worms quite manageable. C. elegans 
proceed through their life cycle in approximately three days and have a lifespan 
of about three weeks. Adults lay eggs which hatch into the first larval stage (L1). 
Under normal conditions (when food is present and temperature is near 20°C), 
the worms proceed through a series of molts, entering the second, third, and 
fourth larval stages (L2, L3, and L4, respectively) before becoming adults 
capable of laying their own eggs (Byerley et al., 1976; Hope, 1999). As the 
worms are mostly hermaphroditic (approximately 99%), one worm is able to 
generate approximately 300 progeny. However, rare males are present (less 
than 1%), an asset to conducting genetic experiments since various strains can 
be crossed with one another (Brenner, 1974). C. elegans can be frozen at -80°C 
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indefinitely in small vials allowing researchers to maintain large quantities of 
stocks with varying genetic backgrounds for long periods of time, thawing them 
only when a particular worm strain is desired (Brenner, 1974; Hope, 1999). 
The large body of knowledge that is available to those using C. elegans, 
such as the mapping of cell lineages (Sulston and Horvitz, 1977), makes their 
use straightforward, particularly from a developmental and genetic standpoint. 
The mapping of cell lineages allows researchers to determine potential 
developmental defects while the ability to manipulate genes allows for the 
generation of mutants, which can be analyzed using a variety of methods such 
as behavioral tests, reproduction analysis, and lethality studies. Additionally, 
many resources are available to C. elegans researchers, such as libraries of 
various strains including the Caenorhabditis Genetics Center (CGC) at the 
University of Minnesota, online resources such as www.wormbase.org and 
www.wormbook.org (Antoshechkin and Sternberg, 2007). 
Since an appropriate biological model must have substantial similarities 
between the organism tested and the organism of interest, C. elegans must 
contain many similarities with other organisms, namely mammals. Conservation 
of physiological processes and signaling pathways make C. elegans a good 
biological model for mammals (National Research Council, 2000). The genome 
has been extensively studied and numerous C. elegans genes have high 
homology with mammalian genes. Homologues for 60-80% of human genes 
have been found in C. elegans (Kaletta and Hengartner, 2006).  
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Nervous system 
The C. elegans nervous system is well-characterized and a complete 
wiring diagram is available (Sulston, 1983; Sulston et al., 1983). It contains only 
302 neurons of 118 subtypes (Chalfie and White, 1988; Hobert, 2005), 6393 
chemical synapses, 890 electrical junctions, and 1410 neuromuscular junctions 
(Chen et al., 2006). The presence of C. elegans strains expressing fluorescent 
proteins in specific neuronal subtypes allows for specific neuronal subtypes in the 
live worm to be observed. Additionally, the functions of many of these neurons 
have been determined by laser ablation and drug exposure studies allowing 
behavioral studies to reveal alterations in neuronal networks (Avery and Horvitz, 
1989). 
Well-characterized behaviors of C. elegans can be experimentally 
assessed for changes, e.g., disruptions in regular movement including alterations 
in typical sinusoidal movement or alterations in swimming behavior if placed in a 
drop of liquid; many of these assays have been automated to allow for higher 
throughput analysis. C. elegans typically move in a sinusoidal motion on agar 
plates as they consume bacteria. C. elegans’ response to various stimuli can 
also be assessed by observing chemotaxis (Li et al., 2009), learning (Zhang et 
al.), and mating behavior (Hope, 1999; Leung et al., 2008; Peterson et al., 2008). 
 
Toxicological model 
 Due to its advantages as a research tool, C. elegans makes for a practical 
means for studying toxic compounds. Research to determine the relevance to 
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mammalian systems has been conducted, showing that the results obtained from 
tests measuring the dose at which 50% of C. elegans die (LD50) and tests 
measuring the LD50 of mammals are comparable, making C. elegans a useful 
early model for toxicity testing (Williams and Dusenbery, 1988). Williams and 
Dusenbery (Williams and Dusenbery, 1987) outlined its potential use as a 
screening test for neurotoxicants, including metal species, using behavioral 
testing. The use of lethality, reproduction, and behavioral tests for determining 
toxicity has been investigated, resulting in the determination that lethality is the 
least sensitive endpoint but that behavior and reproduction were much more 
sensitive, and yielded similar results. More recently, researchers have used C. 
elegans to elucidate the mechanisms of toxicity and the potential for various 
toxicants to induce alterations in expression of particular genes. Analysis of 
testing conditions (such as developmental stage, food presence, and salt 
content) has shown that factors such as medium ionic concentration and pH 
impacted the results, while other factors such as age of the C. elegans and 
presence of E. coli as a food source did not have a significant effect on the 
results when testing for survival (Donkin, 1995).  
 As a toxicological model, C. elegans has been shown to be predictive of 
mammalian toxicity. Many studies have been conducted investigating the toxicity 
of various compounds including pesticides (Cole et al., 2004), mitochondrial 
inhibitors (Ishiguro et al., 2001; Braungart et al., 2004; Ved et al., 2005), and 
metals (Roh et al., 2006). These studies showed that the LD50 values in worms 
correlate with the LD50 values found in rats and mice, with results demonstrating 
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that C. elegans is useful as a predictive model for neurological and 
developmental toxicity studies in mammalian species. Although LC50 levels of 
metallic salts in C. elegans (for example, Hg levels at 100 mg/L in the presence 
of bacteria), were higher than LD50 levels in mammalian systems (Hg levels at 7 
mg/kg in rats and mice and an average of 15 mg/kg in all mammals), the relative 
order of toxicity of metals and other compounds was extremely similar in worms 
and mammalian systems (Williams and Dusenbery, 1988). 
  Many neurotoxicological endpoints have been investigated using the C. 
elegans model system, including behavioral abnormalities, assessment of 
alterations in specific molecular pathways, genetic screening, and specific 
damage to the C. elegans nervous system. To evaluate the cytotoxic potential of 
MeHg, we took a comprehensive approach to examine and understand the 
stress response and adaptation. 
 
Tools for studying C. elegans: RNAi 
 Researchers made headway in determining the molecular consequences 
of toxicant exposure using the C. elegans model system. The availability and 
ability to generate knockout worms along with the availability of various 
techniques such as microarrays, RNAi, and GFP-tagging have greatly aided this 
effort. Most recently DNA microarray has been used to investigate the genomic 
gene expression of C. elegans, and it was used successfully in investigations of 
genes expressed differentially during development (Jiang et al., 2001), aging 
(Lund et al., 2002), and exposure to toxicants (Reichert and Menzel, 2005). 
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Using this technique, Reichert et al. (Reichert and Menzel, 2005) demonstrated 
that exposure to different xenobiotics leads to downregulation of certain genes 
and induction of those that codify detoxifying enzymes. For example, they found 
that of the compounds they tested, fluoranthene was able to induce the most 
genes, including those belonging to the cytochrome P450, and GST families. 
 RNAi in C. elegans is a very useful technique and in 2006 Andrew Fire 
and Craig Mello received the Nobel Prize in Physiology or Medicine for their work 
in this area (Fire et al., 1998). RNAi can be effectively used to silence particular 
genes of interest by injecting, feeding, or soaking the worms in the interfering 
double-strand RNA (dsRNA). It can also be used as a screening tool to 
determine which genes may be necessary for C. elegans to mount an 
appropriate response to a toxicant to avoid an undesired outcome (death, 
movement defects, decrease in progeny generation, etc.). RNAi has emerged as 
one of the most powerful tools for functionally characterizing large sets of 
genomic data. Only recently has the technology advanced to a state where large 
scale screens can be performed and RNAi libraries covering approximately 90% 
of the genome are publicly available (Kamath and Ahringer, 2003; Fewell and 
Schmitt, 2006). The use of RNAi in C. elegans brought important advances to the 
toxicity field, e.g., in the research for mechanisms of action of toxicants, in the 
identification of new therapeutic targets, and to elucidate mechanisms of human 
diseases (Wolters and MacKeigan, 2008).  
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Tools for studying C. elegans: mutagenesis 
 The distinct advantages of C. elegans allow them to be quickly grown in 
large quantities and mutagenized using various mutagens to conduct forward 
genetic screens. Following mutagenesis, C. elegans can be tested on a variety of 
parameters including, for example, resistance or hypersensitivity to toxicants. 
Researchers can expose mutagenized worms to levels of toxicants known to be 
lethal to wild type worms, and, if the mutagenized worms are able to survive, 
these worms can be investigated to assess the identity of the mutation and 
understand how it makes them more resistant to the toxicant than the wild type 
worms. Once a resistant or hypersensitive mutant is identified, the mutation is 
located using 2- and 3-point mapping and confirmed using single gene rescue or 
RNAi phenocopying (Hodgkin, 1999). Forward genetics is efficient for studying C. 
elegans because mutants can include genes expressed in a variety of tissues. C. 
elegans are hermaphroditic, so homozygous mutant strains can be produced in 
the F2 generation via self-crossing. 
 
Tools for studying C. elegans: behavioral analysis 
 Tests that examine various behavioral endpoints and alterations in 
neurons and neurotransmitter systems in C. elegans have been developed 
including those that examine feeding, locomotion, memory, and movement. 
Using toxicants, researchers have conducted many experiments to examine 
behavioral outcomes following exposure. Feeding alterations decreased upon 
exposure to some metals (Jones and Candido, 1999; Boyd et al., 2003) and have 
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been examined in a high-throughput manner (Boyd et al., 2007). Chemotaxis and 
altering behavior to avoid a toxicant have been observed upon exposure to some 
metals (Sambongi et al., 1999; Hilliard et al., 2005). Learning, the ability to 
associate a particular temperature with food and return to that temperature under 
starvation conditions, was also affected by toxicant exposure (Ye et al., 2008). 
Many researchers have examined the ability of C. elegans to move properly 
following toxicant exposure, often using computer tracking systems to enable the 
high throughput assessment of many worms. Since the nervous system in C. 
elegans has been so well characterized, alterations in specific behaviors can be 
attributed to particular circuits and can lead to further investigation of those 
circuits. The locomotor neuronal network in C. elegans is formed by the A- and 
B-type motor neurons and the inhibitory D-type motor neurons that receive their 
input from the interneurons AVA, AVB, AVD, and PVC (Riddle, 1997). Tracking 
systems that examine alterations in movement can indicate alterations in these 
neurons or circuitry. 
 
Tools for studying C. elegans: neuroanatomy 
 As previously noted, C. elegans has a very well characterized nervous 
system, allowing for the analysis of cell number and location as well as 
connectivity. Due to the availability of strains (from sources such as the CGC) 
expressing markers such as green fluorescent protein (GFP) in specific neuronal 
subsets, researchers can directly examine the appearance of the nervous system 
following toxicant insult to assess endpoints including alterations in location of 
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neurons, alterations in outgrowths, and degeneration. Although alterations in 
function are not assessed, the ability to view the nervous system in a live animal 
is extremely useful and predicted to be of high value to toxicologists studying 
agents thought to induce degeneration or alterations in nervous system 
architecture or wiring. 
 
Metal toxicity testing in C. elegans 
 C. elegans has been used as a model system to elucidate the toxicity and 
toxicological mechanisms of various heavy metals, such as aluminum (Al), 
arsenic (As), barium (Ba), cadmium (Cd), copper (Cu), lead (Pb), mercury (Hg), 
uranium (U), and zinc (Zn) (Williams and Dusenbery, 1988). In general, these 
studies focused on various toxic endpoints, such as lethality, reproduction, 
lifespan, and protein expression. Some focus has also been directed to the 
effects of these metals on the nervous system by assessing behavior, reporter 
expression, and neuronal morphology (Dhawan et al., 1999). 
 For instance, a defect in locomotion reflects an impairment of the neuronal 
network formed by the interneurons AVA, AVB, AVD, and PVC providing input to 
the A- and B-type motor neurons (responsible for forward and backward 
movement), and the inhibitory D-type motor neurons involved in the coordination 
of movement (Riddle, 1997). By recording short videos and subsequently 
analyzing them using computer tracking software, it has been possible to quantify 
the overall movement of C. elegans (distance traveled, directional change, etc.), 
body bends, and head thrashes upon metal treatments, allowing to further 
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correlate the data with damage to neuron circuitry. These computer-tracking 
studies showed that worms displayed a dose-dependent decrease in locomotory 
movement upon exposure to Pb (Johnson and Nelson, 1991; Anderson et al., 
2001; Anderson et al., 2004) and Al (Anderson et al., 2004), while an increase in 
locomotion was observed upon exposure to low concentrations of Hg as 
compared with Cu (Williams and Dusenbery, 1988). Another study showed that 
exposure to Ba impaired both body bend and head thrashing rates in a dose-
dependent manner (Wang and Wang, 2008), corroborating mammalian data on 
the effect of Ba on the nervous system attributed to its ability to block potassium 
channels (Johnson and Nelson, 1991). 
 Feeding behavior has also been shown to be affected upon heavy metal 
exposure. Feeding requires a different neuronal circuitry including M3 (involved 
in pharyngeal relaxation), MC (control of pumping rate), M4 (control of isthmus 
peristalsis), NSM (stimulate feeding), RIP (ring/pharynx interneuron), and I 
(pharyngeal interneurons) neurons (Riddle, 1997). A decrease in feeding was 
observed when worms were exposed to Cd or Hg (Jones and Candido, 1999; 
Boyd et al., 2003). 
 Behavioral research studying the effect of heavy metals on C. elegans has 
also taken the route of assessing the ability of the worm to sense the toxicant 
and alter its behavior accordingly, involving other neural circuitry, such as the 
amphid and phasmid neurons responsible for chemosensation (Riddle, 1997). By 
generating concentration-gradient containing plates, Sambongi et al. (Sambongi 
et al., 1999) discovered that C. elegans was able to avoid Cd and Cu but not Ni, 
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and that the amphid ADL, ASE, and ASH neurons were responsible for this 
avoidance as their combined ablation eliminated the avoidance phenotype. 
Furthering the investigation into the role of ASH neurons, researchers found that 
a Ca2+ influx could be elicited upon exposing the C. elegans to Cu, which may 
provide insight into the mechanism of the ability of the worm to display avoidance 
behaviors (Hilliard et al., 2005). 
 C. elegans exhibits both short-term and long-term learning-related 
behaviors in response to specific sensory inputs (Rankin et al., 1990), which 
involve defined neuronal networks. As an example, thermosensation-associated 
learning and memory rely on the AFD sensory neuron sending inputs to the AIY 
and AIZ interneurons, whose signals are integrated by the RIA and RIB 
interneurons to command the RIM motorneuron (Mori et al., 2007). When 
assessing the function of this circuitry, worms grown and fed at a defined 
temperature are moved to a food-deprived test plate exposed to a temperature 
gradient. The ability of the worms to find and remain in the area of the test plate 
corresponding to the feeding temperature reflects the functioning of the 
thermosensation learning and aforementioned memory network (Mori et al., 
2007). Interestingly, worms exposed to Al and Pb exhibit poor scores at this test, 
indicative of a significant reduction of the worms’ learning ability (Ye et al., 2008). 
This recapitulates the learning deficits observed in young patients overexposed 
to the same metals (Garza et al., 2006; Goncalves and Silva, 2007). 
 While behavioral testing was indicative of the neuronal circuitries affected 
by heavy metals, additional experiments uncovered the molecular mechanisms 
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of their neurotoxic effects. For example, in the previously described study, after 
determining that Al and Pb induced memory deficits, the investigators showed 
that the antioxidant vitamin E effectively reversed these deficits, indicating that 
oxidative stress plays a role in Al and Pb neurotoxicity (Ye et al., 2008). The 
involvement of oxidative stress in metal-induced toxicity was further confirmed 
when worms mutated in glutamylcysteine synthetase (gcs-1), the rate-limiting 
enzyme in glutathione synthesis, exhibited hypersensitivity to As exposure when 
compared to wildtype animals (Liao and Yu, 2005). Studies conducted in 
mammalian models found that Hg is able to block Ca2+ channels. In neurons, this 
blockage can induce spontaneous release of neurotransmitters (Atchison, 2005). 
In C. elegans, the Ca2+ channel blocker was found to protect against Hg 
exposure, suggesting that Ca2+ signaling plays a role in the toxicity of Hg in this 
model organism as in mammals (Koselke et al., 2007). 
 Observation of neuron morphology following heavy metal exposure was 
also performed using C. elegans strains expressing GFP in discrete neuronal 
populations. Tests using depleted U evoked no alterations in the dopaminergic 
nervous system of C. elegans, an observation corroborated with data from 
mammalian primary neuronal cultures (Jiang et al., 2007). Meanwhile, kel-8 (a 
Kelch-like protein involved in degradation of glutamate receptors (Schaefer and 
Rongo, 2006)) and numr-1 (a nuclear-localized metal responsive element 
(Tvermoes and Freedman, 2008)), which are involved in resistance to Cd toxicity, 
were upregulated upon Cd exposure. In particular, GFP levels of KEL-8::GFP 
and NUMR-1::GFP were increased in the pharynx and the intestine in addition to 
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the constitutive expression observed in AWA neurons, indicating that these 
proteins may be involved in toxicity or protection (Freedman et al., 2006; Jackson 
et al., 2006; Cui et al., 2007). Furthermore, numr-1 was shown to be induced in 
response to heavy metals, such as Cd, Cu, Cobalt (Co), Chromium (Cr), Ni, As, 
Zn, and Hg, further indicating its involvement in the response to these metals. 
NUMR-1::GFP was localized to nuclei within the intestine and the pharynx and 
co-localized with the stress-responsive heat-shock transcription factor HSF-
1::mCherry (Tvermoes and Freedman, 2008). This indicates that these particular 
genes were altered in response to heavy metals and demonstrates the utility of 
using GFP reporters to guage the involvement of various proteins in responses to 
toxicants. This type of research may aid in the understanding of the toxicity of or 
the protection against these and other agents. 
 Previous research has been conducted exposing C. elegans to Hg and 
measuring a variety of endpoints, including lethality (Williams, 1990; Donkin, 
1995), induction of transgenes (Cioci, 2000), and movement (Williams and 
Dusenbery, 1987). However, this previous research has largely dealt with Hg in 
the form of HgCl2, not organic forms of the metal. Lethality testing from other labs 
has shown that inorganic Hg is able to kill the nematode in a dose-dependent 
manner (Williams and Dusenbery, 1988; Williams, 1990; Donkin, 1995), and 
initial studies in our lab on organic forms of Hg, including MeHg and EtHg, have 
demonstrated the lethal effect of these compounds on C. elegans. However, to 
our knowledge, no other research has been conducted using C. elegans to 
determine the toxicity of MeHg. Due to its strength as a model system for the 
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dissection of genetic contributors to toxicity, use of C. elegans for these tests will 
permit elucidation of the potential mechanisms of the profound neurotoxicity 
observed upon developmental exposure to MeHg. 
 
Proteins linked to MeHg toxicity in mammals are conserved in C. elegans 
 C. elegans displays high homology to mammalian systems, and contains 
many of the genes known to be involved in MeHg toxicity, including GSH, HSPs, 
and MTs and undergoes processes involved in toxicity such as hormesis. 
Additionally, C. elegans contains a homolog of Nrf2, skn-1. Previous work in C. 
elegans has shown gst-4 upregulation in response to a variety of stressors, 
including paraquat (Tawe et al., 1998), juglone (Kampkotter et al., 2007; Kahn et 
al., 2008), hyperbaric oxygen (Link and Johnson, 2002), progesterone (Custodia 
et al., 2001), diethylstilbetrol (Reichert and Menzel, 2005), and acrylamide (Tawe 
et al., 1998; Hasegawa et al., 2008); hsp-4 (a member of the HSP70 family) in 
response to heat, tunicamycin (Calfon et al., 2002), and irradiation (Bertucci et 
al., 2009); and mtl-1 and mtl-2 in response to cadmium, uranium and heat 
(Freedman et al., 1993; Swain et al., 2004; Jiang et al., 2007). Hormesis has 
been previously observed in C. elegans. Following dietary restriction or exposure 
to sublethal heat stress, animals display an increase in lifespan and a resistance 
to exposure to a subsequent stressor (Cypser et al., 2006). C. elegans express 
nearly 50 GSTs (van Rossum et al., 2001), approximately 10 HSPs of the HSP70 
family (Heschl and Baillie, 1989), and 2 MTs (Freedman et al., 1993). We chose 
to examine gst-4, hsp-4, and both mtl-1 and mtl-2. gst-4 is highly homologous 
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with human glutathione-requiring prostaglandin D synthase (Wormbase). hsp-4 
has high homology with human heat shock 70 kDa protein 5 (HSPA5), a 78 kDa 
glucose-regulated protein precursor (GRP78) (Wormbase). In C. elegans, this 
protein has been shown to be induced upon accumulation of unfolded proteins 
(Shen et al., 2001) and in hormesis induced by heat stress (Olsen et al., 2006). 
Although the C. elegans MTs have marked differences from the mammalian MT 
genes, such as differences in their organization and in their coding and flanking 
sequences, they have many important shared elements, such as the high Cys 
content in the form of a Cys-X-Cys motif (Freedman et al., 1993). mtl-1 is most 
highly homologous with human MT-3 while mtl-2 is most highly homologous with 
human keratin-associated protein 5-9 (Wormbase).  
 
The proposed research program: use of C. elegans to assess MeHg 
cytotoxicity 
 Our initial hypothesis was that MeHg would induce structural changes in 
the C. elegans nervous system, and that we could glean information about the 
molecular mechanisms of these alterations by using the genetic tractability of this 
platform. The goal of our experiments was to determine the mechanisms of 
MeHg toxicity, specifically in the nervous system. Since the toxicity of MeHg had 
never before been tested on C. elegans, our first aim was to elucidate the overall 
effects of the toxicant on this model organism. Our initial experiments included 
the measurement of many endpoints including lethality, Hg accumulation, 
lifespan, brood size, growth, and behavior. MeHg did induce lethality and a 
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developmental delay, likely due to a decrease in pharyngeal pumping rate. 
However, in animals surviving the initial MeHg insult, at Hg concentrations 
equivalent to those found to cause neuronal abnormalities in mammalian 
systems (Falluel-Morel et al., 2007; Helmcke et al., 2009), it failed to induce 
alterations in lifespan (more than 24 hours after treatment), brood size, or 
thrashing rate. These results gave us a general understanding of the effect of 
MeHg on the organism as a whole. The lack of an obvious movement phenotype 
and the lack of MeHg-dependent alterations in lifespan and brood size were 
surprising given the known literature on the effects of other toxicants on C. 
elegans and the effects of MeHg in mammalian systems. 
 Due to the known effects of MeHg on the nervous system and the 
extensive characterization of the C. elegans nervous system, our second aim 
addressed the ability of MeHg to induce morphological alterations in the neurons 
of C. elegans, such as the ability of cells to reach the proper location and form 
proper outgrowths. Since data in mammalian systems have revealed gross 
morphological changes to the structure of the nervous system following exposure 
to MeHg, we hypothesized that the nervous system of C. elegans would also 
exhibit morphological alterations following exposure to the toxicant. Neither 
qualitative observations of a number of neuronal subtypes including 
dopaminergic, GABAergic, serotonergic, glutamatergic, and cholinergic nor in-
depth quantitative analysis of dopaminergic and GABAergic neurons elucidated 
morphological changes in these neurons. These studies addressed the structure 
of the nervous system, but did not assess alterations in the functioning of the 
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neurons. The lack of changes in the structure of the nervous system was 
surprising; however, it is corroborated with the lack of alterations in behavioral 
assays. Since MeHg is a neurotoxicant in mammals which induces morphological 
changes, our results indicate that C. elegans may express unique mechanisms to 
cope with the MeHg insult, affording it increased resistance. 
 We had expected to observe alterations in the nervous system that might 
display as obvious movement phenotypes or morphological changes. The third 
and final aim of this work examined mechanisms of MeHg resistance to 
determine molecules and pathways involved in C. elegans resistance to MeHg. 
In these experiments, we assayed the involvement of GSH, HSPs, and MTs in 
MeHg toxicity while also examining the ability of MeHg to induce hormesis in C. 
elegans. Since each of these systems had shown involvement in both MeHg 
toxicity and preconditioning in other models, we expected to see alterations in 
their expression level and alterations upon exposing molecular mutants to the 
toxicant. Based on prior literature reports, we expected that MeHg would cause 
the generation of ROS and direct protein damage by binding to Cys groups on 
various proteins. We predicted that these effects would trigger a cascade of 
events that would result in a number of alterations including upregulation of 
HSPs, MTs, and GSTs, while depleting GSH through the generation of GSSG 
and the expulsion of the GS-MeHg complex (Figure 1A). We also hypothesized 
that if we used animals lacking any of those components, the animal would be 
more sensitive to MeHg than its wild-type counterpart. Additionally, we theorized 
that MeHg would be able to induce a hormetic effect in C. elegans and that the 
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proteins involved in MeHg detoxification noted above were involved in this 
response. 
 To test our hypotheses, we used GFP reporter strains to quantify changes 
in gst-4, hsp-4, and mtl-1 in response to MeHg exposure. We further examined 
the role of GSH by measuring GSH and GSSG, which varied based on exposure 
duration and stage at exposure.  
 MeHg caused a hormetic response in C. elegans, suggesting that MeHg 
could evoke a protective pathway in this organism. Although our data indicate 
that gst-4 induction plays a robust role in the hormetic response, other 
preconditioning-associated proteins including hsp-4, mtl-1, and mtl-2 were 
unchanged. 
 Taken together, our results indicate that MeHg does not induce overt 
morphological alterations in the C. elegans nervous system, yet the nematode is 
a valuable model organism for neurotoxicological research. The continuation of 
this line of experimentation can provide insights into the mechanisms by which C. 
elegans is able to protect itself from MeHg insult, for example, by metabolism of 
the metal or efficient repair mechanisms. These results could provide 
investigators with tools necessary to enable them to prevent or minimize MeHg 
toxicity in humans. 
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CHAPTER II 
 
CHARACTERIZATION OF THE EFFECTS OF MEHG ON C. ELEGANS 
 
Summary 
 The rising prevalence of methylmercury (MeHg) in seafood and in the 
global environment provides an impetus for delineating the mechanism of the 
toxicity of MeHg. Deleterious effects of MeHg have been widely observed in 
humans and in other mammals, the most striking of which occur in the nervous 
system. Here we test the model organism, Caenorhabditis elegans (C. elegans), 
for MeHg toxicity. The simple, well-defined anatomy of the C. elegans nervous 
system and its ready visualization with green fluorescent protein (GFP) markers 
facilitated our study of the effects of methylmercuric chloride (MeHgCl) on neural 
development. Although MeHgCl was lethal to C. elegans, induced a 
developmental delay, and decreased pharyngeal pumping, other traits including 
lifespan, brood size, swimming rate, and nervous system morphology were not 
obviously perturbed in animals that survived MeHgCl exposure. Despite the 
limited effects of MeHgCl on C. elegans development and behavior, intracellular 
mercury (Hg) concentrations (< 3 ng Hg/mg protein) in MeHgCl-treated 
nematodes approached levels that are highly toxic to mammals. If MeHgCl 
reaches these concentrations throughout the animal, this finding indicates that C. 
elegans cells, particularly neurons, may be less sensitive to MeHgCl toxicity than 
mammalian cells. We propose, therefore, that C. elegans should be a useful 
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model for discovering intrinsic mechanisms that confer resistance to MeHgCl 
exposure. 
 
Introduction 
 For a thorough review of Hg toxicology, please see dissertation 
introduction. MeHg is of particular concern due to its ability to pass through the 
blood-brain and placental barriers where it molecularly mimics methionine and 
enters cells via the large amino acid transporter, LAT1 (Kerper et al., 1992; 
Simmons-Willis et al., 2002; Yin et al., 2008) allowing MeHg to accumulate in 
both the brain and the fetus. MeHg has varying effects on the nervous system 
based on age at exposure. Although MeHg possesses high affinity for cysteine, 
allowing it to bind thiol groups, and can accumulate within astrocytes, the specific 
molecular targets of MeHg are largely unknown (Aschner et al., 1990; Kerper et 
al., 1992; Simmons-Willis et al., 2002). 
Despite many years of investigation, numerous questions surround the 
mechanisms of MeHg toxicity in mammals. Investigators have taken various 
approaches to study MeHg toxicity using many model systems including rat, 
mouse, zebrafish, and cell culture. However, these systems are limited by their 
complexity or removal from an intact organism. To address this, we have 
adopted an alternative approach of using the model organism, Caenorhabditis 
elegans (C. elegans), to study MeHg toxicity.  
C. elegans has been used extensively in biological research and provides 
many advantages, including its small size, rapid life cycle, self-fertilization, and 
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ready genetic manipulation; the C. elegans nervous system has been mapped, 
and its genome fully sequenced (Sulston and Horvitz, 1977; Sulston, 1983; White 
et al., 1986; Wood, 1988; C. elegans sequencing consortium, 1998). Earlier 
studies of toxicity in C. elegans have revealed high predictive value for 
mammalian systems (Williams and Dusenbery, 1988; National Research Council, 
2000; Cole et al., 2004; Leung et al., 2008). In addition to measurements 
investigating effects on the overall health of C. elegans (lethality, life span, brood 
size, behavior, etc.), some assessments included determination of gene 
induction using reporter strains and protection afforded by a particular gene 
through the use of knockout, over-expression strains, RNAi, or mutagenesis 
experiments (Leung et al., 2008). 
We used C. elegans to study MeHg toxicity and tested several different 
endpoints including lethality, Hg accumulation, lifespan, brood size, body length, 
overall development, swimming behavior, and pharyngeal pumping rate. We also 
used green fluorescent protein (GFP) markers for specific neuronal populations 
to assess the development and appearance of the nervous system following 
methylmercuric chloride (MeHgCl) insult.  
Our studies revealed that Hg approached levels (≤3 ng Hg/mg protein) in 
C. elegans tissues that are highly toxic to mammals (for example, in rat brain, 
0.05 ppm resulted in significant structural alterations (Falluel-Morel et al., 2007)). 
Although exposure to MeHgCl induced dose-dependent developmental delay 
and lethality, surviving animals were surprisingly unaffected. The absence of 
observable defects in development or morphology in the C. elegans nervous 
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system is particularly noteworthy given the sensitivity of mammalian neurons to 
MeHg. Our results indicate that C. elegans may exhibit unique mechanisms for 
detoxifying, trafficking, or metabolizing MeHgCl that render its nervous system 
resistant or inaccessible to MeHg. 
 
Methods 
C. elegans Maintenance 
 C. elegans were grown on plates containing nematode growth medium 
(NGM) seeded with Escherichia coli strain OP50 as previously described 
(Brenner, 1974). Unless otherwise noted, hermaphroditic wildtype N2 Bristol 
strain was used for all experiments. Transgenic lines expressing promoter GFP 
reporters used in this study were: NW1229 F25B3.3::GFP (a marker of Ras1 
guanine nucleotide exchange factor, pan-neuronal GFP expression) (Altun-
Gultekin et al., 2001), LX929 unc-17::GFP (a marker of a synaptic vesicle 
acetylcholine transporter, labels cholinergic neurons) (Chase et al., 2004), 
CZ1200 unc-25::GFP (a marker of glutamic acid decarboxylase, labels 
GABAergic neurons) (Huang et al., 2002), EG1285 unc-47::GFP (a marker of a 
transmembrane vesicular GABA transporter, labels GABAergic neurons) 
(McIntire et al., 1997), TL8 cat-1::GFP (a marker of a synaptic vesicular 
monoamine transporter, labels catecholaminergic neurons) (Colavita and 
Tessier-Lavigne, 2003), GR1333 tph-1::GFP (a marker of tryptophan 
hydroxylase, labels serotonergic neurons) (Sze et al., 2000), DA1240 eat-4::GFP 
(a marker of vesicular glutamate transporter, labels glutamatergic neurons) 
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(Asikainen et al., 2005) (all obtained from the Caenorhabditis Genetics Center, 
Minneapolis, MN) BY250 dat-1::GFP (a marker of the dopamine transporter, 
labels dopaminergic neurons) (Nass et al., 2001), and F49H12.4::GFP (labels 
PVD neurons) (Watson et al., 2008). 
 
MeHgCl Treatments 
 Animals were treated with an alkaline bleach solution to obtain a 
synchronous population prior to treatment with MeHgCl (Stiernagle, 1999) and 
synchronized populations of selected larval stages (either L1 or L4) were treated. 
Treatment was conducted by combining larvae (2500 L1s or 300 L4s), 
concentrated OP50, the appropriate volume of MeHgCl dissolved in water, and 
M9 buffer to a volume of 500μL in 1.7 mL siliconized tubes. Following the desired 
treatment duration (30 minutes to 15 hours), animals were washed twice with 
deionized water by centrifugation and placed on OP50-containing NGM plates. 
 
Lethality 
 Following MeHgCl treatment and washing, animals were transferred 
(approximately 300 per plate) to 60 mm NGM plates seeded with OP50 and 
allowed to grow for 24 hours. Animals were then counted and scored as dead or 
alive. Viability was scored based on appearance and ability to move in response 
to poking with a platinum wire (Bischof et al., 2006; Roh et al., 2007). 
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Determination of Hg Content 
 C. elegans larvae were treated with MeHgCl as described above. After 24 
hours of culture on OP50-containing NGM plates, both live and dead animals 
were collected and washed twice with deionized water. For L1 treatments, 
approximately 10,000 animals were pooled and assessed, for L4 treatments, 
approximately 900 animals were pooled and assessed. As expected, protein 
content was higher in samples treated with lower concentrations of MeHgCl. 
Average protein content per sample was approximately 110 mg, ranging from 16 
mg to 254 mg. The pelleted pool of live and dead worms was sonicated and a 
small aliquot was used for protein measurement; the remainder of the sample 
was used for inductively coupled plasma-mass spectrometry (ICP-MS) analysis 
of Hg content. Although it is possible that some demethylation occurred during 
the study, it is unlikely that an appreciable amount of inorganic Hg was formed. 
This would be an interesting extension of this research, however due to small 
sample size, information regarding the potential demethylmation of MeHg could 
not be collected in this study. Protein content was determined following 
manufacturer instructions for a bicinchoninic acid (BCA) protein assay kit (Pierce, 
Rockford IL). Preparation of the sample for ICP-MS involved addition of nitric 
acid followed by heat digestion and dilution of the samples with water. The 
samples were digested in PP tubes (352059, BD) in a block heater after addition 
of 65% HNO3 (Merck, Suprapur). The samples were transferred to Teflon tubes 
and digested in an UltraClave (Milestone). After digestion the samples were 
diluted directly in the Teflon tubes with ultrapure water (PURLAB Ultra Analytic, 
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Elga) to achieve a final acid concentration of 0.6 mol/L. High Resolution-
Inductively Coupled Plasma-Mass Spectrometry (HR-ICP-MS) analysis was 
performed using a Thermo (Finnigan) model Element 2 instrument (Bremen, 
Germany). The RF power was 1400 W. The sample was introduced using an SC-
2 with SC-FAST option auto sampler (ESI, NE, USA) with a peristaltic pump 
(pump speed 0.25 mL/min). The instrument was calibrated using 0.6 mol/L HNO3 
solutions of multielement standards at appropriate concentrations. Internal 
standards were not used. To check for possible drift in the instrument, a standard 
solution with known elemental concentrations was analyzed for every 10 
samples. In addition, blank samples (0.6 mol/L HNO3, Suprapur) were analyzed 
for approximately every 10 samples. The samples were analyzed in random 
order, and the analyst was not aware of the identity of the samples. Hg was 
determined in the low resolution mode (M/Δm=300). 
 
Lifespan and Brood Size Analysis 
For lifespan assays, 40 live C. elegans hermaprodites from each MeHgCl 
concentration group were picked to a fresh NGM plate 24 hours following 
treatment. On each succeeding day, worms were counted and scored as live or 
dead. Live C. elegans were picked to fresh plates every day during egg-laying 
and every other day once they ceased laying eggs until no live C. elegans 
remained. The experiment was carried out in quadruplicate. 
 For brood size analyses, one live C. elegans was placed on each of four 
NGM plates per treatment concentration 24 hours after MeHgCl exposure. Every 
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24 hours, this animal was transferred to a new NGM plate until no new progeny 
were generated in a 24-hour period. The progeny on each of the fresh plates 
were counted and the experiment was carried out in quadruplicate. This 
approach allowed the measurement of the overall number of progeny generated 
and the interval between MeHgCl exposure at different concentrations and 
progeny generation. 
 
Measurement of Size and Developmental Progress 
 Following treatment and washing, C. elegans were imaged on a Nikon 
Eclipse 80i microscope. Body length was measured using Nikon Element 
software to trace the body contour from the posterior bulb of the pharynx to the 
anus. Twenty worms per treatment were also assessed for their development 
through the larval stages using the following criteria: L1s had 4 or fewer gonadal 
cells, L2s had more than 4 gonadal cells and the gonad had begun to extend 
along the length of the animal, L3 worms had undergone further extension of the 
gonad and vulval morphogenesis had begun to occur, L4s displayed dorsal 
rotation of the gonad, and adults had observable eggs. 
 
Behavioral Analysis: Pharyngeal Pumping and Thrashing Rates 
 Pharyngeal pumping rate was assessed using a Leica MZ16FA 
microscope following MeHgCl treatment and washing. Pumps per minute were 
manually counted following treatment with MeHgCl. To test thrashing rates, C. 
elegans were placed in 10uL of water on a Pyrex Spot Plate and their behavior 
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was videotaped through a microscope for three minutes, as previously described 
(Matthies et al., 2006). Briefly, AVI movies were generated using a frame grabber 
Piccolo graphics card (Ingenieur Helfrich) and VidCap32 AVI capture application 
(Microsoft, Redmond, CA). The movies were analyzed using a script written in 
MatLab 7.0.1 (MathWorks, Natick, MA) to determine the position of the worm in 
each frame using motion detection and selection of a pixel designating the 
centroid of the worm (available upon request). Worm oscillation over time was 
displayed following calculation of movement in Hz. Four worms per treatment 
were tested in each behavioral analysis. 
 
Microscopic Observation of Neurons 
 GFP-reporter strains were treated with MeHg as described above (30-
minute treatment of L1 and 15-hour treatment of L4 animals followed by washing 
and culture on OP50-containing NGM plates). C. elegans treated at the L1 or L4 
stage and the progeny of those worms treated at the L4 stage were observed 
using a Nikon Eclipse 80i microscope. Quantitative analysis of dat-1::GFP worms 
involved counting the number of head neurons (4 CEPs and 2 ADEs), projections 
from CEP neurons to the tip of the nose, and neurons in the C. elegans body (2 
PDEs). Quantitative analysis of unc-25::GFP worms involved counting the 
number of head neurons (4 RMEs), the number of neurons along the ventral 
nerve cord (13 VDs and 6 DDs), the number of commissures traveling across the 
body, and whether there were any breaks in the commissures or the nerve cord. 
Other GFP strains (F25B3.3::GFP, unc-17::GFP, unc-47::GFP, cat-1::GFP, tph-
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1::GFP, eat-4::GFP, F49H12.4::GFP) were examined to assess for obvious 
changes in overall structures of the labeled neurons. 
 
Statistics 
 GraphPad Prism 4 was used to assess significance, for dose response, 
Hg content, brood size, pharyngeal pumping rate, thrashing rate, body length, 
and neuronal quantification, ANOVA with Bonferroni’s Multiple Comparison Test 
was applied, for lifespan, log rank test was applied. When p-values were lower 
than 0.05, groups were considered significantly different, higher than 0.05 were 
not considered significantly different. 
 
Results 
C. elegans larvae are sensitive to MeHgCl 
 Dose-response curves were generated to test for dose-dependent toxicity 
of MeHg to C. elegans. L1 and L4 larval stages were selected to coincide with 
developmental processes in the worm (L1) and of the germ line of the worm (L4). 
Worms treated for 30 minutes with MeHg at the L1 stage [LC50=1.08 mM, n=10 
(throughout document, each ‘n’ is one separate experiment, usually conducted at 
least in triplicate)] were significantly (p<0.001) more sensitive to MeHg compared 
with worms treated at the L4 stage (LC50=4.51 mM, n=6) (Figure 2A). 
Additionally, increasing the duration of MeHg exposure in L4 worms from 30 
minutes to 6 hours (LC50=0.57 mM, n=6) and 15 hours (LC50=0.33 mM, n=9)  
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Figure 2. Dose–response curve of lethality of MeHgCl to C. elegans. Worms 
treated at L1 (LC50=1.08±0.02, n=10 p<0.001) were more sensitive to the 
toxicant than worms treated at the L4 stage (LC50=4.51±0.01, n=6) (A). Toxicity 
increased as exposure duration increased, L4 worms were treated for 15 h 
(LC50=0.33±0.01, n=9), for 6 h (LC50=0.57±0.01, n=6), and for 30 min 
(LC50=4.51±0.01, n=6) (B). 
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statistically significantly (p<0.001) increased the toxicity to C. elegans, indicating 
that longer exposures are more lethal to C. elegans (Figure 2B).  
 
Hg accumulates in a dose-dependent manner in animals treated with 
MeHgCl 
 Hg content was measured for selected exposures for different treatments, 
including L1 treatment for 30 minutes and L4 treatment for 30 minutes, 6 hours, 
and 15 hours (n=3 for each treatment). Exposures tested were selected to 
represent a range of doses that corresponded to a low concentration (LC0), at 
least one medium concentration (LC20-LC80), and at least one high concentration 
(LC100) for each of the conditions tested. Hg content was not tested when dose-
response curves indicated death of all worms. The resulting values indicate that  
there is an increase in Hg content with increased MeHgCl exposure (Figure 3). 
Comparing the animals treated for 30 minutes and for 15 hours at L4, Hg content 
was significantly higher following a treatment at 0.1 and 0.4 mM MeHgCl 
(p<0.05) with the longer exposure. As the MeHgCl concentration to which the 
worms were exposed increased, Hg content also increased. After treatment of L1 
animals for 30 minutes, worms treated at 1 mM MeHgCl contained significantly 
more Hg than control-treated worms (*, p<0.05). After treatment of L4 worms for 
30 minutes, worms treated at all MeHgCl concentrations had significantly higher 
Hg content than control-treated worms (*, p<0.05). Additionally, animals treated 
with 1 and 10 mM MeHgCl contained significantly more Hg than those treated 
with 0.1 or 0.4 mM MeHg (*, p<0.05). Following a 6-hour treatment, L4 worms 
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treated with 0.4 mM MeHg contained significantly more Hg than the control-
treated worms (*, p<0.05). Following 15-hour treatment at L4 stage, control 
worms (0 mM MeHgCl) contain an average of 0.02 ng Hg/mg protein, whereas 
those treated at 0.1 and 0.4 mM MeHgCl contain an average of 0.45 and 3.34 ng 
Hg/mg protein, respectively (p<0.001 vs. controls). As duration of exposure 
increases, Hg accumulation in C. elegans significantly increased in a time-
dependent manner (Figure 3). For instance, when L4s were treated for 30  
minutes at 0.4 mM MeHgCl, the average Hg content was 0.29 ng Hg/mg protein; 
when the duration of exposure increased to 6 hours and 15 hours, average Hg 
content increased to 0.81 and 3.34 ng Hg/mg protein, respectively (p<0.01). A 
comparison of the Hg content of L1s and L4s treated for 30 minutes revealed that 
L1s had significantly lower levels of Hg (p<0.01). This finding indicates that L1s 
may be more sensitive to Hg than the dose-response curves (Figure 2) revealed, 
as they are killed at lower levels of internal Hg than are L4 animals with 
comparable Hg content.  
 
MeHgCl does not alter lifespan or brood size of C. elegans  
 For animals that survive exposure to MeHgCl, longevity did not seem to 
correlate with exposure dose (Figure 4). For example, average lifespan following 
a 30-minute treatment of L1 C. elegans (Figure 4A) or a 15-hour treatment of L4 
C. elegans was 13-15 days (Figure 4B). Additionally, we tested the lifespan of 
the progeny of L4 C. elegans treated for 15 hours, which had an average lifespan 
of 15-17 days (Figure 4C). None were significantly altered when using the log 
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Figure 3.  Hg content in C. elegans following MeHgCl exposure. Hg content was 
measured as a function of sample protein content (n=3). Hg content significantly 
increased as the duration of exposure to MeHgCl increased and as the MeHgCl 
treatment concentration increased.  
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Figure 4. Lifespan is unaltered following MeHgCl in C. elegans. Animals treated 
for 30 min at L1 stage (A) and 15 h at L4 stage (B) had an average lifespan of 
13–15 days following treatment while progeny of animals treated for 15 h at L4 
stage (C) had an average lifespan of 15–17 days (n=5). 
 53
rank test to compare the control and MeHg-treatment groups (n=5). In measuring 
brood size, the same three populations (L1 30-minute treatment, L4 15-hour 
treatment, and progeny of L4 treatment) were tested (Figure 5). Animals that 
underwent 15-hour L4 treatment had an overall decrease in brood size (progeny 
generation of L1 30-minute treated worms at 0 mM MeHgCl was 279±14, of L4 
15-hour treated worms was 221±11, and of progeny of L4 15-hour treated worms 
was 243±13). However, the only significant MeHg-dependent alteration in brood 
size occurred when L1 30-minute treated worms were exposed to 1 mM MeHgCl 
(187±21 progeny generated compared to 279±14 progeny generated under 
control conditions, p<0.001). There were no other statistically significant 
alterations in brood size (n=6). 
 
MeHgCl treatment retards C. elegans larval development 
 Following treatment with MeHgCl, C. elegans length was altered in a 
dose-dependent manner, with higher MeHgCl doses correlating with shorter 
length (Figure 6). This observation prompted an investigation into a potential 
developmental delay of C. elegans following MeHgCl treatment. This study 
detected a corresponding dose-dependent developmental delay (Figure 7, Table 
1, n=5 experiments). Under normal conditions at 20°C, C. elegans 
embryogenesis takes 14 hours, and then the worm undergoes a series of molts 
at 29, 38, 47, and 59 hours post fertilization (Hope, 1999). Retarded development 
occurred in both the worms treated at the L1 stage for 30 minutes and those 
treated at L4 for 15 hours. After growth for 24 hours, control-treated L1 larvae 
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Figure 5. C. elegans brood size is unaltered following MeHgCl exposure. Animals 
treated for 30 min at L1 stage, 15 h at L4 stage, and progeny of those treated for 
15 h at L4 stage demonstrated no dose-dependent alteration in brood size (n=6). 
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Figure 6. Body length of C. elegans was shorter following treatment with 
MeHgCl. After growth for 24 or 48 h, animals treated at either L1 (C and E) or L4 
(G) stages with the toxicant were significantly ( p < 0.001, n=4) shorter than 
control animals (B, D, and F), as measured using the Nikon Element software to 
measure their length in pixels (arbitrary units) according to their body contour 
from the posterior bulb of the pharynx to the anus (A). 
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Figure 7. C. elegans larvae were developmentally delayed following exposure to 
MeHgCl. Animals treated at higher concentrations of MeHgCl took longer to 
develop through the larval stages and into adults following a 30-minute exposure 
at L1 stage (A–C) or a 15-hour exposure at L4 stage (D-E). 
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Table 1. MeHgCl developmentally delays C. elegans. Following control or 
MeHgCl treatment, life stages of worms were assessed. Percentages of worms 
at each larval stage or at adult stage are indicated (n=5). 
 
35.0065.000.00100.000.4
95.005.0015.0085.000.1
100.000.0032.5067.500
AdultL4AdultL4mM MeHgCl
Chronic L4 39H postChronic L4 24H post
71.0025.004.007.5037.5055.0047.0053.001
91.009.000.0020.0061.2518.7584.0016.000.4
95.005.000.0077.5013.758.7599.001.000.1
95.005.000.0070.0018.7511.25100.000.000
AdultL4L3L4L3L2L2L1mM MeHgCl
Acute L1 72H postAcute L1 48H postAcute L1 24H post
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had all reached the L2 stage while many worms treated at higher concentrations 
of MeHgCl remained L1s (Figure 7A). This trend continued 48 (Figure 7B) and 72 
(Figure 7C) hours after treatment, when most worms had reached the adult 
stage. This trend also occurred in animals treated for 15 hours at the L4 stage 
(Figure 7D-E). Many control-treated animals reached the adult stage 24 hours 
after treatment while those treated at higher MeHgCl had remained L4s (Figure 
7D). At 48 hours after treatment, all control-treated worms had reached the adult 
stage, while only some of those treated with higher MeHgCl concentrations had 
reached the adult stage (Figure 7E) (n=5 experiments). 
 
Pharyngeal pumping decreases following MeHgCl exposure, thrashing is 
unaffected 
 Pharyngeal pumping rates were significantly decreased in a dose-
dependent manner following 15-hour treatment of L4 C. elegans with MeHgCl 
(control-treated worms pumped at a rate of 230±6 pumps per minute 24 hours 
following treatment while worms treated at 0.1 and 0.4 mM MeHgCl pumped at 
168±9 and 69±11 pumps per minute, respectively, p<0.001, Figure 8). Other 
researchers have demonstrated that at the L4 stage, C. elegans typically pump 
at a rate of 150-200 pumps per minute. The rate increases as they mature into 
adults and peaks 2 days later at 300-350 pumps per minute before declining as 
the worm ages (Huang et al., 2004). Since the pumping rates observed in our 
experiments were lower than expected even for L4 C. elegans, we do not 
attribute this decrease to the developmental delay. A similar trend was observed  
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Figure 8. Pharyngeal pumping rates of C. elegans decrease following MeHgCl 
exposure. Number of pharyngeal pumps per minute significantly decreased in a 
dose-dependent manner following 30 minute MeHgCl exposure of L1 worms 48 h 
following treatment at 0.75 and 1 mM MeHgCl (**p<0.01, n=12) and 72 h 
following treatment at 1 mM MeHgCl (*p<0.05, n=12). Exposure of L4 worms for 
15 h induced a decrease in pharyngeal pumping rate 24 h following exposure at 
0.4, 0.6, and 0.75 mM MeHg (*p<0.05, n=11). No alteration in pharyngeal 
pumping rate was noted in progeny of L4-treated animals (n=8). 
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in animals treated at the L1 stage for 30 minutes, and significant differences were 
noted between control worms and those treated at 0.4 and 1 mM MeHgCl 
(p<0.05). The decreased pumping rate induced by MeHgCl could contribute to 
the decreased rate of development in worms. No alterations were seen in the 
pumping rate of the progeny of C. elegans treated for 15 hours at the L4 stage at 
any concentration tested (0.1, 0.2, 0.3, and 0.4 mM MeHgCl, n=7). Thrashing 
data showed no trends in MeHgCl-dependent alterations on the swimming 
behavior of C. elegans (Figure 9). [There was one outlier among worms treated 
as L4s for 15 hours at 0.1 mM MeHgCl 24 hours following treatment. Mean 
thrashing rate was 0.27 (p<0.05) while thrashing means for all other groups 
ranged from 0.38 to 0.65 and were not statistically significantly different from 
each other (n=6, data not shown)]. 
 
Alterations in neuronal morphology were not observed in worms that 
survived MeHgCl exposure 
 GFP markers were used to observe cholinergic, glutamatergic, 
serotonergic, dopaminergic, and GABAergic neuronal populations for potential 
alterations following MeHgCl insult. Animals were treated with 0, 0.1, 0.4, and 1 
mM MeHgCl for a 30-minute treatment at the L1 stage, and a 15-hour treatment 
at the L4 stage. Live worms treated at the L1 stage were observed 24, 48, and  
72 hours following treatment and worms treated at the L4 stage were observed 
24 and 48 hours following treatment. Additionally, progeny of L4-treated animals 
were observed once they reached the L4 stage. No obvious phenotypes were 
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Figure 9. Thrashing rate of animals treated as L1s for 30 min or as L4s for 15 h 
and progeny of L4s treated for 15 h was not altered in a MeHgCl-dose-
dependent manner (n=6). 
 
 62
 observed in these neuronal populations under any of the treatment paradigms.  
 Due to ease of measurement because of a low cell number and readily 
available GFP markers, dopaminergic and GABAergic neuronal populations were 
quantitatively investigated. Analysis of the dopaminergic system revealed no 
alteration in cell number [6 head neurons (Figure 10C) and 2 PDEs (Figure 10D)] 
or ability of projections to travel from the nerve ring to the tip of the nose (Figure 
10E) in worms surviving MeHgCl insult (Figure 10A-B). GABAergic analysis also 
revealed no alteration in cell number in the head (Figure 11C) or nerve cord 
(Figure 11D), ability of projections to pass across the body (Figure 11E), or 
number of breaks in the commissures (Figure 11F) of C. elegans surviving 
MeHgCl treatment (Figure 11A-B).  
 
Discussion 
 Here we describe our first experiments to probe the neurotoxicity of 
MeHgCl in the model organism, C. elegans. No neuronal alterations were 
observed upon MeHgCl exposure, indicating that the C. elegans nervous system 
may possess unique mechanisms for dealing with the insult of this toxicant. 
However, the possibility does exist that MeHg is metabolized, excreted, or 
sequestered from neurons, resulting in minimal exposure to these cells. Other 
results (lethality, pharyngeal pumping, etc.) demonstrate MeHgCl toxicity to C. 
elegans and begin to reveal some of the alterations that occur following exposure 
to this metal. Lethality was observed at high MeHgCl doses (Figure 2). As has 
been shown in other systems, MeHgCl was more toxic to younger as compared 
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Figure 10. Representative dopaminergic C. elegans neurons following MeHgCl 
insult. Cells and projections are identical under control (A) and MeHgCl treatment 
(B) conditions (at all concentrations observed, 0.1, 0.4, and 1 mM MeHg) 
following treatment at L1 for 30 min or L4 for 15 h (n=4). Progeny of worms 
treated at L4 for 15 h were also unaffected (n=4). Upon quantification of 
dopaminergic head neurons (CEPs and ADEs) (C), dopaminergic body neurons 
(2 PDEs) (D), dopaminergic projections from the head to the anterior tip of the 
worm (CEPs) (E), no significant MeHgCl concentration-dependent alterations 
were detected (n=4). 
 64
A B
Control MeHgCl-treated
0.00.10.41.0 0.00.10.41.0 0.00.10.41.0 0.00.10.41.0 0.00.10.41.0 00.10.4 1
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
Acute GABA head neurons 24H
Acute GABA head neurons 48H
Acute GABA head neurons 72H
Chronic GABA head neurons 24 H
Chronic GABA head neurons 48 H
Progeny GABA head
neurons
[MeHgCl] (mM)
N
um
be
r 
of
 H
ea
d
N
eu
ro
ns
0.00.10.41.0 0.00.10.41.0 0.00.10.41.0 0.00.10.41.0 0.00.10.41.0 00.10.4 1
0
5
10
15
20
Acute GABA NC neurons 24 H
Acute GABA NC neurons 48 H
Acute GABA NC neurons 72 H
Chronic GABA NC neurons 24 H
Chronic GABA NC neurons 48 H
Progeny GABA NC
neurons
[MeHgCl] (mM)
N
um
be
r 
of
 N
er
ve
 C
or
d
N
eu
ro
ns
0.00.10.41.0 0.00.10.41.0 0.00.10.41.0 0.00.10.41.0 0.00.10.41.0 00.10.4 1
0
5
10
15
20
Acute GABA commissures 24 H
Acute GABA commissures 48 H
Acute GABA commissures 72 H
Chronic GABA commissures 24 H
Chronic GABA commisures 48 H
Progeny GABA
commissures
[MeHgCl] (mM)
N
um
be
r 
of
C
om
m
is
su
re
s
0.00.10.41.0 0.00.10.41.0 0.00.10.41.0 0.00.10.41.0 0.00.10.41.0 00.10.4 1
0.0
0.1
0.2
0.3
0.4
0.5
Acute GABA breaks 24 H
Acute GABA breaks 48 H
Acute GABA breaks 72 H
Chronic GABA breaks 24 H
Chronic GABA breaks 48 H
Progeny GABA breaks
[MeHgCl] (mM)
N
um
be
r 
of
 b
re
ak
sF
D
E
C
N
um
be
r 
of
 H
ea
d
N
eu
ro
ns
N
um
be
r 
of
 N
er
ve
 C
or
d
N
eu
ro
ns
N
um
be
r 
of
C
om
m
is
su
re
s
N
um
be
r 
of
 b
re
ak
s
 
 
Figure 11. Representative GABAergic C. elegans neurons following MeHgCl 
insult. Cells and projections are identical under control (A) and MeHgCl treatment 
(B) conditions (at all concentrations observed, 0.1, 0.4, and 1 mM MeHg) 
following treatment at L1 for 30 min or L4 for 15 h (n=4). Progeny of worms 
treated at L4 for 15 h were also unaffected (n=4). Upon quantification GABAergic 
head neurons (C), GABAergic commisures (D), GABAergic nerve cord neurons 
(E), or beaks in GABAergic projections (F), no significant MeHgCl concentration-
dependent alterations were detected (n=4). 
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to older individuals (Clarkson and Magos, 2006). However, this result cannot be 
explained by increased accumulation of MeHgCl in younger C. elegans as the 
young (L1) worms accumulated less Hg than their older (L4) counterparts (Figure 
3). Instead, the enhanced sensitivity of L1 stage larvae may be due to inhibition 
of essential developmental pathways including, for example, mechanisms for 
detoxifying MeHgCl that could be in place in the more mature L4 larvae. 
Mammalian systems have displayed an inability to demethylate MeHg until after 
birth, indicating that in mammals, the processes involved in demethylation as a 
form of detoxification do not develop until later in life (Dock et al., 1994). 
Furthermore, MeHgCl displayed increased toxicity as duration of exposure 
increased (Figure 2), indicating that increased accumulation of Hg within C. 
elegans (Figure 3) may be responsible for this increased toxicity instead of an 
increased duration of exposure to the toxicant. 
 Although our studies required exposure of C. elegans to relatively high 
external doses of MeHgCl, Hg accumulation within C. elegans is not excessively 
high when compared to levels observed in the brains of mammals exposed to 
MeHgCl. In our studies, the levels observed in worms ranged from 0-3.3 ng 
Hg/mg protein. A number of studies have investigated Hg levels in mammalian 
brain following MeHgCl treatment. In human autopsy studies, brain levels of Hg 
between 1913 and 1970 decreased, from an average level of 34 parts per million 
(ppm) to an average level of 1.3 ppm (1 ppm equals 1 ng/mg) (Kevorkian et al., 
1972). Examples of determination of Hg content following MeHgCl exposure 
include rats treated with MeHgCl, registering Hg levels of 0-8 ppm, depending on 
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dosage and duration (Newland et al., 2006) and mice treated with MeHgCl 
having 0-3 ppm when pregnant mice were exposed and their pups tested at 
various postnatal days (Stringari et al., 2008). A single dose of 5 μg/g body-
weight MeHgCl in rat pups, resulting in brain Hg levels of approximately 0.05 
ppm, produced extensive alterations in the brain, including reduced hippocampal 
size and cell number as well as deficits in learning (Falluel-Morel et al., 2007). 
Furthermore, Hg levels in Minimata disease patients have been measured at 
1.60 ppm in umbilical cord samples (Harada, 1995). Alterations in the C. elegans 
nervous system would have been expected due to the body of literature 
indicating that alterations are seen in the nervous system of other organisms at 
the concentrations observed in C. elegans. For example, in rodent studies, 
damage to the nervous system has been observed at 4.5 ppm for 
neuropathological damage and 0.5 ppm for neurobehavioral alterations (Castoldi 
et al., 2008), and in children the threshold for clinical effects is 1 ppm in the brain 
(Burbacher et al., 1990). Comparing these to our experiments, where levels 
reached 3.3 ppm in C. elegans, concentrations of Hg as high as those found in 
mammalian systems where deleterious alterations have been observed were 
measured. Additionally, brain levels in human brains have been assessed from 
individuals in the Seychelles (1.475 ngHg/mg protein) (Lapham et al., 1995), in 
Minimata patients (2 ngHg/mg protein) (Takeuchi, 1985), and in Iraqi patients 
(68.5 ng/mg protein) (Choi et al., 1978). Although levels in Iraqi patients were 
much higher than those we measured, the presence of toxicity in Minimata 
patients and some evidence of alterations in individuals in the Seychelles 
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suggest that, at the levels we measured in C. elegans (0-3.3 ng Hg/mg protein)
neuronal abnormaliti
, 
es would be expected. 
 Neither C. elegans lifespan (Figure 4) nor brood size (Figure 5) was 
altered upon MeHgCl exposure possibly indicating that essential reproductive 
processes are resistant to the effects of MeHgCl and that the aging process in C. 
elegans is not accelerated by exposure to MeHgCl. Hg concentrations were not 
tested more than 24 hours following treatment, but Hg may be excreted at a high 
rate, decreasing the effect of MeHg after a number of days. Stress factors or 
detoxification may also be induced following toxicant exposure, allowing C. 
elegans to cope with MeHgCl following the initial insult much more efficiently 
compared to mammalian systems. Additionally, the C. elegans reproductive 
system may be less sensitive to MeHgCl toxicity. However, a decrease in C. 
elegans size (Figure 6) and a developmental delay following MeHgCl exposure 
was noted (Figure 7, Table 1). Taken together, these results indicate that C. 
elegans may have a mechanism for stunting development when stressed with 
MeHgCl and returning to normal development once more favorable conditions 
are encountered. Developmental delay in C. elegans is not unique to MeHgCl 
exposure, as researchers investigating other chemicals have observed similar 
outcomes. Some toxicants have had more dramatic effects, for example, 
exposure to antipsychotic compounds led to larval arrest and dauer formation 
(Donohoe et al., 2006) whereas exposure to ethanol led to a decrease in brood 
size and life span in addition to a developmental delay (Davis et al., 2008). 
Although no alteration in thrashing behavior was noted (Figure 9), the decreased 
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pharyngeal pumping rate following MeHgCl exposure (Figure 8) indicates that C. 
elegans may consume less bacteria following exposure. It is possible that 
decreased feeding could be an adaptive response to limit MeHgCl intake as well 
as delay development until a less toxic environment is attained. Although gross 
morphological alterations in neurons were not noted, MeHgCl may have specific 
effects on the neurons of the pharyngeal nervous system, leading to the 
alterations in pharyngeal pumping rate. Further investigation of the pharyngeal 
nervous system morphology or functioning should reveal insights into the 
mechanism of the decreased pumping rate. 
 Extensive research investigating alterations in mammalian brain and 
mammalian cell lines following exposure to MeHgCl has revealed mitotic arrest in 
the cerebellum (Rodier et al., 1984), necrosis and apoptosis (Castoldi et al., 
2001), disruption of microtubules (Castoldi et al., 2001), alterations in calcium 
levels and signaling, oxidative stress (Castoldi et al., 2001), and alterations in 
neurotransmitter systems (Sobotka et al., 1974; Castoldi et al., 2001), specifically 
in the glutamatergic (Brookes, 1992; Aschner, 2000; Baraldi et al., 2002), 
muscarinic cholinergic (Coccini et al., 2000), and dopaminergic (Rossi et al., 
1997; Faro et al., 2002) systems. Although a major target of MeHg toxicity in 
mammals is the nervous system (Clarkson and Magos, 2006), surprisingly, 
alterations in the nervous system of C. elegans were not observed.  
 There are a number of possible explanations for this observation. The 
experiments described here assess the overall function of selected behavioral 
circuits (thrashing and pharyngeal pumping) but do not assay the function of 
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specific individual neurons which therefore could be selectively inactivated by 
MeHgCl treatment. Although we did not observe significant changes in neuron 
morphology, the neuron-specific GFP markers used in our study would not have 
revealed functional defects in synaptic activity. MeHg may not reach sufficiently 
high concentrations in C. elegans to have a deleterious effect on the nervous 
system before the animal is affected in some other way, i.e., another tissue is 
damaged, leading to lethality. Another possible explanation is that C. elegans 
neurons utilize mechanisms to overcome the toxicity of MeHg that are not 
similarly activated in mammalian neurons. The elucidation of such mechanisms 
may reveal pathways that could be exploited in cases of MeHg poisoning in 
humans. Interestingly, quantification of alterations in the nervous system (Figure 
10-11) did not reveal any alterations in appearance of neurons although, as 
indicated by dose-response curves, some animals were likely sick or dying.  
 Dead animals could not be assessed since autofluorescence within the 
entire animal makes the GFP reporter indistinguishable from the rest of the 
animal. However, C. elegans were observed at time points during exposure and 
at various time points after exposure, no trends existed indicating that neurons 
were affected before death of the animal. This result shows that these worms are 
most likely not dying due to perturbations within the nervous system but via 
alternative mechanisms that do not affect the nervous system. We propose that 
C. elegans may exhibit a potent adaptive response, such as the involvement of 
glutathione or metallothioneins, allowing the neurons to survive MeHgCl insult. 
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 Taken together, our experiments show that while MeHgCl is toxic to C. 
elegans, the nervous system of this model organism does not appear to be as 
sensitive to MeHg as mammalian neurons. Therefore, additional studies in C. 
elegans may reveal unique mechanisms of MeHg handling, allowing us to glean 
important information by making use of many advantages that C. elegans 
provides as a model organism with resistance to MeHg neuronal toxicity. 
 
 71
CHAPTER III 
 
HORMETIC EFFECT OF MEHG ON C. ELEGANS 
 
Summary 
 Extensive research has demonstrated some of the toxic effects of 
methylmercury (MeHg), yet the molecular mechanisms underlying its toxicity 
remain largely unknown. C. elegans offers a unique biological model to explore  
the mechanism of MeHg toxicity given the many advantages associated with its 
ease of use and genetic power. Since our previous studies indicated that C. 
elegans is resistant to MeHg neurotoxicity, the present study was designed to 
examine the molecular mechanisms associated with this resistance. We 
hypothesized that since glutathione (GSH), heat shock proteins (HSPs), and 
metallothioneins (MTs) have shown involvement in MeHg toxicity, the toxicant  
would induce expression of gst-4::GFP, hsp-4::GFP, mtl-1::GFP, and mtl-2::GFP 
in C. elegans. Our studies demonstrated a modest, but significant increase in 
fluorescence in gst-4::GFP and mtl-1::GFP strains at an acute, low MeHgCl 
exposure at the L1 stage, while a chronic MeHgCl exposure at the L4 stage 
induced increases in gst-4::GFP and hsp-4::GFP. Knockout gst-4 animals 
showed no alterations in MeHgCl response compared to wildtype animals while 
mtl knockouts displayed increased sensitivity to MeHgCl exposure. GSH levels 
were increased in acute MeHgCl exposure and depleted in chronic exposure. We 
also demonstrated the ability of MeHgCl to induce hormesis, an adaptive 
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phenotype whereby a sublethal exposure to MeHgCl rendered C. elegans 
resistant to a subsequent exposure to the organometal. The involvement of gst-4, 
hsp-4, mtl-1, and mtl-2 in the hormetic response was examined. An increase in 
gst-4::GFP expression after a low-dose acute exposure to MeHgCl indicated that 
gst-4 is critical for this response. Our results implicate GSH, HSPs, and MTs in 
protecting C. elegans from MeHg toxicity and show that gst-4 is involved in 
MeHgCl-induced hormesis. 
 
Introduction 
 See the introduction of this dissertation for a detailed review of MeHg 
toxicity and the use of C. elegans as a model system. We designed experiments 
in C. elegans to determine the molecular mechanisms of proteins previously 
demonstrated to play a role in MeHg detoxification in an effort to better 
understand the adverse health effects of MeHg in humans. 
 Prior work described in this dissertation indicated that there are no 
appreciable morphological alterations in GABAergic, dopaminergic, cholinergic, 
glutamatergic, or serotonergic neuronal subtypes in response to MeHg insult, 
showing that the C. elegans nervous system demonstrates resistance to the 
toxicant at concentrations equivalent to those known to be detrimental to the 
mammalian nervous system (Helmcke et al., 2009). A number of proteins are 
involved in the detoxification and excretion of MeHg; these include glutathione 
(GSH), heat shock proteins (HSPs), and metallothioneins (MTs).  
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 GSH is a tripeptide consisting of glutamic acid, cysteine, and glycine and 
can exist in the reduced (GSH) or the oxidized (GSSG) state. GSH is oxidized to 
form GSSG in the presence of reactive oxygen species (ROS). GSSG can then 
be converted back into GSH via glutathione reductase (GR) and the conversion 
of NADPH to NADP+ (Filomeni et al., 2005). Alternatively, glutathione s-
transferases (GSTs) can catalyze the conversion of GSH to GS-, which can bind 
to MeHg and facilitate its excretion from the body (Figure 12)(Hirata and 
Takahashi, 1981). Under normal conditions, HSPs function as molecular 
chaperones, assisting with protein folding, directing proteins to proper organelles, 
assembly and disassembly of protein complexes, and inhibition of aggregation. 
Upon stress, for example in the presence of MeHg (Sacco et al., 1997), these 
proteins function to assist in the refolding and repair of denatured proteins and 
can facilitate new protein synthesis (Hubbard and Sander, 1991).  
 MTs are small, cysteine-rich metal binding proteins that are involved in 
metal detoxification and homeostasis and can protect cells from oxidative stress 
through this role and as their role as antioxidants (Maret, 2008). Due to their high 
cysteine content, they have a high affinity for MeHg. Additionally, MeHg has been 
shown to induce expression of these MTs (Rising et al., 1995; Tsui and Wang, 
2005) and alterations in behavior of MT-null animals (Yoshida et al., 2008). 
Although GSH, HSPs, and MTs have been implicated in resistance to MeHg 
toxicity, researchers have yet to elucidate their precise role in detoxification.  
 We chose C. elegans as the preferred experimental model system 
because of the resistance of its nervous system to MeHgCl. To determine  
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GS-MeHg
GST
NADPH+H+NADP+  
Figure 12. Glutathione cycle. GSH is converted to GSSG upon exposure to ROS. 
GR can convert GSSG back to GSH while converting NADPH to NADP+. GSTs 
can assist with the conjugation of GSH to MeHg for excretion from the system. 
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whether GSTs, HSPs, or MTs play a role in MeHgCl detoxification, we examined 
their expression through the use of GFP reporter strains. We observed induction 
of gst-4 and hsp-4, and mtl-1 following exposure to MeHgCl. 
 Hormesis refers to a process whereby a sublethal stressor renders an 
organism more resistant to subsequent stress. This has been demonstrated in a 
number of models, ranging from cell cultures to humans under a variety of stress 
conditions, including dietary restriction, exercise, radiation, exposure to various 
chemicals including metals, and heat (Damelin et al., 2000; Cypser et al., 2006; 
Mattson, 2008b; Bourg, 2009). Although the precise mechanisms of hormesis are 
unknown, previous research has identified proteins and elucidated mechanisms 
that may be involved, including HSPs of the HSP70 family and MTs, both of 
which can be upregulated following exposure to heavy metals (Damelin et al., 
2000). Additionally, a time lag is often observed between MeHg exposure and 
the appearance of symptoms of toxicity. Hormetic mechanisms have been 
implicated as a possible explanation of this latency (Weiss et al., 2002). We 
designed studies to assess the ability of MeHgCl to induce a hormetic response 
in C. elegans. Hormesis has been previously observed in C. elegans. Following 
dietary restriction or exposure to sublethal heat stress, animals display an 
increase in lifespan and a resistance to exposure to a subsequent stressor 
(Cypser et al., 2006). We examined the role of gst-4, hsp-4, and mtl-1 and mtl-2 
in the observed hormetic response by assessing the ability of C. elegans to 
display a hormetic response following exposure to sublethal concentrations of 
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MeHgCl. We hypothesized that MeHgCl would induce expression of these 
proteins and cause increases in GFP expression.  
 The overall goal of our studies, therefore, was to address the mechanism 
of action of MeHgCl toxicity and gain a better understanding into the resistance 
of the C. elegans nervous system to MeHgCl. We set to explore several proteins 
previously shown to be involved in MeHg resistance with a secondary objective 
of linking them to the hormetic effect of MeHg. 
 
Materials and Methods 
C. elegans maintenance and strains 
 C. elegans were cultured on nematode growth medium (NGM) plates 
seeded with Escherichia coli strain OP50 as previously described (Brenner, 
1974). In addition to the wildtype N2 Bristol strain, transgenic lines expressing 
GFP reporters used in this study were: CL2166 gst-4::GFP (Link and Johnson, 
2002), SJ4005 hsp-4::GFP (Calfon et al., 2002) (obtained from the 
Caenorhabditis Genetic Center (CGC), Minneapolis, MN), mtl-1::GFP, and mtl-
2::GFP (both gifts of the lab of Dr. Jonathan Freedman). The following knockout 
strains were also used: RB1823 gst-4 (ok2358), VC128 mtl-2 (gk125) (both 
obtained from the CGC, Minneapolis, MN), mtl-1 (tm1770), and double mtl-1/2 
(zs1) knockouts (gifts from Hughes and Sturzenbaum) (Hughes and 
Sturzenbaum, 2007). With the exception of the hsp-4::GFP strain, which was 
kept at 15°C throughout experimentation due to induction of the heat shock 
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proteins at higher temperatures, animals were kept at 20-23°C throughout 
experimentation, and hermaphroditic worms were used in all experiments.  
 
MeHgCl treatments 
 Animals were treated as previously described (Helmcke et al., 2009). 
Briefly, animals were treated with an alkaline bleach solution prior to treatment 
with MeHgCl to obtain a synchronous population (Stiernagle, 1999). C. elegans 
were exposed to MeHgCl in one of two treatment paradigms. In the first 
paradigm, animals were treated for 30 minutes at 18-24 hours after 
synchronization, at the L1 stage. In the second paradigm, animals were allowed 
to grow to the L4 stage following synchronization. They were then treated at the 
L4 stage for 15 hours. All treatments involved combining larvae, (2500 L1s or 
300 L4s), concentrated OP50, the appropriate volume of MeHgCl dissolved in 
water, and M9 buffer to a volume of 500μL in 1.7 mL siliconized tubes. Following 
treatment, animals were washed twice with deionized water by centrifugation and 
placed on OP50-containing NGM plates. For hormesis experiments, animals 
were subjected to a combination of both treatments (Figure 17A). Animals were 
treated under control, 0.3, or 0.6 mM MeHgCl conditions at the L1 stage for 30 
minutes, washed, allowed to recover and grow to the L4 stage on OP50-
containing NGM plates, and then treated at the L4 stage for 15 hours, and 
washed again. Dose-response curves were generated for each treatment 
condition.  
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Hg content 
 C. elegans larvae were treated with MeHgCl as described above. For L1 
treatments, approximately 10,000 animals were pooled and assessed; for L4 
treatments, approximately 900 animals were pooled and assessed. To separate 
live animals from dead animals, a sucrose floatation method was used. After 
treating and washing animals as described above, they were allowed to recover 
for 24 hours on OP50-containing NGM plates. They were then washed off the 
plate and into tubes with cold M9 buffer, centrifuged, and washed again with cold 
M9. After washing, a cold 30% sucrose solution was added to the worms, and 
they were centrifuged again. Worms floating on the top of the sucrose solution 
were live worms and were collected and washed an additional 3 times with M9. 
These samples were then sonicated and analyzed. Protein content was 
determined following manufacturer instructions for a bicinchoninic acid (BCA) 
protein assay kit (Pierce, Rockford IL). The remainder of the sample was used for 
inductively coupled plasma-mass spectrometry (ICP-MS) analysis of Hg content. 
Preparation of the sample for ICP-MS involved addition of nitric acid followed by 
heat digestion and dilution of the samples with water. The samples were digested 
in PP tubes (352059, BD) in a block heater after addition of 65% HNO3 (Merck, 
Suprapur). The samples were transferred to Teflon tubes and digested in an 
UltraClave (Milestone). After digestion the samples were diluted directly in the 
Teflon tubes with ultrapure water (PURLAB Ultra Analytic, Elga) to achieve a final 
acid concentration of 0.6 mol/L. High Resolution-Inductively Coupled Plasma-
Mass Spectrometry (HR-ICP-MS) analysis was performed using a Thermo 
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(Finnigan) model Element 2 instrument (Bremen, Germany). The RF power was 
1400 W. The sample was introduced using an SC-2 with SC-FAST option auto 
sampler (ESI, NE, USA) with a peristaltic pump (pump speed 0.25 mL/min). The 
instrument was calibrated using 0.6 mol/L HNO3 solutions of multielement 
standards at appropriate concentrations. Internal standards were not used. To 
check for possible drift in the instrument, a standard solution with known 
elemental concentrations was analyzed for every 10 samples. In addition, blank 
samples (0.6 mol/L HNO3, Suprapur) were analyzed for approximately every 10 
samples. The samples were analyzed in random order, and the analyst was not 
aware of the identity of the samples. Hg content was determined in the low 
resolution mode (M/Δm=300). 
 
Lethality 
 Following treatment, wild type or knockout animals were placed on 60 mm 
NGM plates seeded with OP50 and allowed to grow for 24 hours. Animals were 
scored as dead or alive based on appearance and ability to move in response to 
being poked with a platinum wire (Bischof et al., 2006; Roh et al., 2007). 
 
Measurement of fluorescence intensity 
 For each strain, control animals were imaged first. The imaging settings, 
including exposure time, were determined based on control animals. A Zeiss 
LSM 510 META upright confocal microscope was used for the imaging of hsp-
4::GFP, mtl-1::GFP, and mtl-2::GFP strains. Autofluorescence was subtracted 
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from each image, allowing for the analysis of GFP intensity using Metamorph 
software. For hormesis experiments and all experiments using the gst-4::GFP 
strain, C. elegans were imaged on a Nikon Eclipse 80i microscope. These 
images were analyzed using NIS-Element Basic Research Software to determine 
the fluorescence intensity of the animals. 
 
Glutathione quantification 
 A scaled-up version of the treatment paradigms described above was 
conducted. C. elegans were treated in 50-mL conical tubes to a volume of 25 mL, 
using 125,000 animals for L1 treatments and 15,000 animals for L4 treatments. 
Following treatment, a pooled sample of live and dead animals were washed 3x 
with dH2O, and duplicates of L4 treatments were pooled to yield 30,000 worms 
for glutathione analysis while L1 treatments were not pooled, yielding 125,000 
animals for glutathione analysis. Immediately following washing, equal volumes 
of C. elegans and 10% perchloric acid/0.2 M boric acid/10 μM γ-
glutamylglutamate were combined with approximately 500 mL of 1.0 mm zirconia 
beads in a 2 mL microtube. Samples were placed in a Mini-Beadbeater (Biospec 
Products, Bartlesville, OK) and beat for 20 seconds, then quickly placed in an ice 
water bath for 1 minute. This cycle was repeated 7 times before the samples 
were centrifuged for 30 minutes at 4°C. The supernatant was removed and 
frozen at -80°C until being subjected to further processing. For glutathione 
measurement, 300 μL sample was combined with 60 μL iodoacetic acid solution 
(14.8 mg/mL H2O). The pH was adjusted to 9.0±0.2 using KOH in saturated 
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potassium tetraborate. After 20-minute incubation, 300 μL dansylchloride solution 
was added (20 mg/mL acetone), samples were mixed and allowed to incubate 24 
hours in the dark. Following this incubation, 500 μL chloroform was added, 
samples were mixed and centrifuged, and aqueous layer was collected for 
injection to obtain HPLC results. HPLC separation was conducted as previously 
described (Reed et al., 1980), using an 80% methanol solution as solvent A, an 
acetate buffered methanol solution as solvent B, and a propylamine column 
(Custom LC, Huston, TX), with detection performed with a fluorescence detector 
with excitation maximum at 335 nm and emission at 515 nm. HPLC results were 
analyzed on a per-worm basis, assuming 125,000 animals per L1 treatment and 
30,000 animals per L4 treatment. 
 
Statistics 
 GraphPad Prism 4 was used to assess significance. For all experiments, 
ANOVA with Bonferroni’s Multiple Comparison Test was applied to raw data. 
When p-values were less than 0.05, groups were considered significantly 
different, groups with p-values greater than 0.05 were not considered significantly 
different. For each experiment discussed, ‘n’ indicates the number of 
experiments, not number of animals. 
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Results 
Hg accumulates in live animals following MeHgCl treatment 
 Hg content was measured in animals that survived a 15 hour exposure at 
the L4 stage at 0, 0.1, and 0.4 mM MeHgCl. Exposures tested were selected to 
represent a range of doses that corresponded to a low concentration (LC0), a 
medium concentration (LC20-LC80), and at a high concentration (LC100). As the 
MeHgCl concentration to which the worms were exposed increased, Hg content 
in the samples analyzed also increased, with Hg levels at 0.015±0.006 ng Hg/mg 
protein for samples treated with 0 mM MeHgCl, 0.297±0.136 ng Hg/mg protein 
for samples treated with 0.1 mM MeHgCl, and 3.775±1.231 ng Hg/mg protein 
(Figure 13). 
 
Increased expression of gst-4, hsp-4, mtl-1, and mtl-2 following MeHgCl 
exposure 
 Immediately following treatment of L1 C. elegans for 30 minutes and of L4 
C. elegans for 15 hours with MeHgCl, fluorescence intensities of gst-4::GFP, 
hsp-4::GFP, mtl-1::GFP and mtl-2::GFP strains were measured. hsp-4::GFP and 
mtl-2::GFP C. elegans displayed no alteration in fluorescence after 30-minute 
treatment at the L1 stage at 0.2 or 0.4 mM MeHgCl. Under this treatment 
paradigm, however, a significant increase was noted in fluorescence of gst-
4::GFP following treatment at 0.2 mM MeHgCl (Figure 14A, p<0.01) and mtl-
1::GFP following treatment at 0.4 mM MeHgCl (Figure 14C, p<0.05) (n=5). These 
data indicate that a short, low exposure to MeHgCl at the L1 stage can induce  
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Figure 13. Concentration of Hg in live animals following MeHgCl exposure.  
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Figure 14. Treatment of gst-4::GFP (A), hsp-4::GFP (B), mtl-1::GFP (C) and mtl-
2::GFP (D) C. elegans with MeHgCl induces increases in GFP fluorescence. 
After an acute treatment at the L1 stage, increases in fluorescence were 
observed in gst-4::GFP (A, p<0.01) and mtl-1::GFP (C, p<0.05) strains (n=5). 
Chronic treatment at the L4 stage induced in increases in fluorescence in gst-
4::GFP (A, p<0.001) and hsp-4::GFP (B, p<0.05) strains (n=5). 
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expression of gst-4 and mtl-1; however, expression of these proteins is not 
induced at a higher concentration of MeHgCl. 
 Following a 15-hour treatment at the L4 stage, a significant increase in 
fluorescence was noted in gst-4::GFP [for which a large (4 fold) increase in 
fluorescence was seen (Figure 14A, p<0.001)] and hsp-4::GFP (Figure 14B, 
p<0.05) while mtl-1::GFP and mtl-2::GFP worms displayed no changes in 
fluorescence intensity (Figure 14C-D) (n=5).  
 
mtl but not gst-4 knockouts display increased sensitivity to MeHgCl 
 Lethality tests of L1 animals treated acutely and L4 animals treated 
chronically were conducted on mtl-1, mtl-2, mtl-1/2, and gst-4 knockouts and 
compared to the lethality of wildtype animals. No significant shifts in dose-
response curves were observed for animals treated acutely at the L1 stage (N2 
LC50=1.08±0.02, mtl-1 LC50=0.78±0.02, mtl-2 LC50=1.15±0.1, mtl-1/2 
LC50=1.12±0.05, gst-4 LC50=0.99±0.01, n=4) (Figure 15A-B) or in gst-4 knockout 
animals treated chronically at the L4 stage (N2 LC50=0.33±0.01, gst-4 
LC50=0.33±0.02, n=4) (Figure 15C). However, all three mtl knockout strains were 
significantly more sensitive to MeHgCl than the wildtype strain (mtl-1 
LC50=0.18±0.05, mtl-2 LC50=0.22±0.02 and mtl-1/2 LC50=0.17±0.02, n=6, p<0.05) 
(Figure 15D). 
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Figure 15. Treatment of knockout animals reveals increased sensitivity in mtl null 
animals following chronic exposure to MeHgCl. Dose response curves following 
acute treatment at the L1 stage did not reveal shifts in gst-4 (LC50=0.99±0.01) 
(A), mtl-1 (LC50=0.78±0.02), mtl-2 (LC50=1.15±0.1), or mtl-1/2 (LC50=1.12±0.05) 
(B) strains when compared to wild type (LC50=1.08±0.02) (n=4). Chronic 
exposure of L4s did not induce a shift in gst-4 animals (LC50=0.33±0.02) (C) as 
compared to wild type (LC50=0.33±0.01) but did induce a significant shift in mtl-1 
(LC50=0.18±0.05), mtl-2 (LC50=0.22±0.02), and mtl-1/2 (LC50=0.17±0.02) strains 
(D, p<0.05) (n=4). 
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MeHgCl induces hormesis in wild-type C. elegans 
 We tested the ability of an acute exposure at the L1 stage to shift the 
dose-response curve of a subsequent exposure to MeHgCl. Animals treated 
under control conditions (e.g. 0 mM MeHgCl) for the initial MeHgCl exposure 
(LC50=0.15±0.004 mM MeHgCl) were significantly (p<0.05) more sensitive to the 
subsequent exposure to MeHgCl than those treated at the 0.3 (LC50=0.19±0.005 
mM MeHgCl) or 0.6 (LC50=0.20±0.004 mM MeHgCl) mM MeHgCl conditions 
when LC50 values were compared (Figure 16). C. elegans with prior exposure to 
MeHgCl were more resistant to the subsequent MeHgCl exposure, as indicated 
by the rightward shift in the dose-response curve. 
 
Contribution of gst-4, hsp-4, mtl-1, and mtl-2 to hormesis 
 We conducted experiments to assess the involvement of gst-4, hsp-4, mtl-
1, and mtl-2 in hormesis. Fluorescence of wild-type gst-4::GFP, hsp-4::GFP, mtl-
1::GFP and mtl-2::GFP strains was measured following exposure to hormesis 
conditions. Animals were imaged immediately before and immediately following 
their second exposure (chronic L4) to MeHgCl. Images collected before the 
second MeHgCl treatment, after an acute L1 treatment followed by washing and 
growth to the L4 stage in the absence of MeHgCl, revealed minimal changes in 
fluorescence intensity. No significant alterations in fluorescence intensity were 
noted in wild-type, mtl-1::GFP, or mtl-2::GFP animals. A significant decrease in 
fluorescence was observed in gst-4::GFP animals treated at both 0.3 and 0.6 mM 
MeHgCl and hsp-4::GFP animals treated at 0.6 mM MeHgCl (Figure 17B,  
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Figure 16. Pretreatment with MeHgCl renders C. elegans more resistant to a 
subsequent exposure to the toxicant. Dose-response curves were significantly 
shifted rightward under 0.3 (LC50=0.19±0.005 mM MeHgCl) or 0.6 
(LC50=0.20±0.004 mM MeHgCl) mM MeHgCl (p<0.05) from control 
(LC50=0.15±0.004 mM MeHgCl) pretreatment conditions. 
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Figure 17. Fluorescence of gst-4::GFP, hsp-4::GFP, mtl-1::GFP, and mtl-2::GFP 
strains following hormesis treatments. Treatment paradigm includes animals 
treated at the L1 stage for 30 minutes, allowed to grow to the L4 stage, assessed 
for fluorescence or treated again and assessed for fluorescence after second 
treatment (A).  Decreases were noted in fluorescence in gst-4::GFP and hsp-
4::GFP animals after a single treatment and recovery (B, n=4). After an initial 
treatment with MeHgCl and subsequent exposure to control treatment conditions, 
gst-4::GFP animals showed an increase in fluorescence (p<0.05). At higher 
subsequent MeHgCl levels and in all conditions of hsp-4::GFP, mtl-1::GFP, and 
mtl-2::GFP worms only decreases in fluorescence at increasing MeHgCl 
concentrations were noted (C-F, n=4). 
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p<0.05). These findings were surprising given the previous findings of increases 
in fluorescence when the hormesis model was not used. 
 After the second treatment of L4 larvae, alterations in fluorescence were 
more dramatic and similar to the trends observed following a single L4 chronic 
treatment. A slight decrease in baseline fluorescence of hsp-4::GFP (Figure 
17D), mtl-1::GFP (Figure 17E), and mtl-2::GFP (Figure 17F) strains was noted as 
the initial, acute MeHgCl concentration increased, and this trend continued in 
animals treated at higher MeHgCl concentrations (p<0.05). However, when the 
chronic treatments varied and the acute treatment was kept constant, an overall 
increase in fluorescence was noted with increasing MeHgCl concentrations 
(p<0.05). In gst-4::GFP L4 animals, dramatic increases in fluorescence were 
observed following chronic treatments with increasing MeHgCl concentrations 
(Figure 17C, p<0.01).  
 By analyzing these data in another way i.e. comparing fluorescence of the 
animals exposed to increasing chronic treatments within each acute paradigm 
(instead of comparing fluorescence of animals exposed to increasing acute 
treatment within each chronic treatment, as described above) significant 
increases in fluorescence are observed (Figure 18). With the exception of hsp-
4::GFP (Figure 18C) animals treated at the 0.6 mM MeHgCl acute exposure 
level, significant increases in fluorescence occur in each of the treatment groups. 
In hsp-4::GFP (Figure 18 C) and gst-4::GFP (Figure 18D) animals, these findings 
confirm the previous results described in this paper, whereby a chronic exposure 
to MeHgCl induces an increase in fluorescence in these animals. However, our  
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Figure 18. Re-analysis of mtl-1::GFP, mtl-2::GFP, hsp-4::GFP, and gst-4::GFP 
fluorescence following hormesis treatments. Acute treatment at the L1 stage with 
MeHgCl is indicated along the Y-axis, chronic treatment at the L4 stage with 
MeHgCl is indicated in the colors/legend. Significant increases (p<0.05) are 
observed in fluorescence of mtl-1::GFP and mtl-2::GFP in each of the 
preconditioning paradigms as the subsequent concentration of MeHgCl 
increases (A-B). When pretreatment is 0.3 mM MeHgCl, hsp-4::GFP 
fluorescence is only increased at the highest (0.4 mM) MeHgCl concentration 
and does not significantly increase when acute treatment is at 0.6 mM MeHgCl 
(C). Large increases in fluorescence were observed in gst-4::GFP animals with 
increased chronic MeHgCl concentrations except at 0.6 mM MeHgCl 
pretreatment and 0.4 mM MeHgCl subsequent treatment (D). 
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previous data presented here did not reveal an increase in fluorescence in mtl-
1::GFP (Figure 14C) or mtl-2::GFP (Figure 14D) animals. The results from these 
hormesis data, therefore, reveal that mtl-1 and mtl-2 can be induced upon a 
second exposure to MeHgCl, but not a single chronic exposure. 
 
MeHgCl induces alterations in glutathione levels 
 Glutathione profiles were different between animals acutely and 
chronically exposed to MeHgCl. After an acute exposure to MeHgCl, a trend of 
increasing GSH and GSH/GSSG ratio were noted while no changes were 
observed in total glutathione levels (Figure 19A). Chronic exposure to MeHgCl 
induced decreases in GSH, GSH/GSSG ratio, and total glutathione levels (Figure 
19B).  
 
Discussion 
 The studies reported here represent the first experiments in C. elegans to 
address the mechanism of action of MeHgCl toxicity in C. elegans and provide 
insights into the unique resistance of the C. elegans nervous system to MeHgCl. 
For the most part, specific molecular mechanisms of MeHgCl resistance are 
unknown. Previous data from our lab (Helmcke et al., 2009) showed that while 
lethality, pharyngeal pumping, growth, and development were affected in C. 
elegans exposed to MeHgCl, brood size, lifespan, thrashing rate, and nervous 
system morphology were largely unaffected. 
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Figure 19. Glutathione levels in C. elegans treated with MeHgCl. Levels of GSH 
and GSSG/GSH ratio increased after acute exposure (A) while these values 
along with total glutathione level decreased after chronic exposure (B). 
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 The current studies showed that in C. elegans, MeHgCl exposure resulted 
in increasing levels of Hg accumulation in animals that survived exposure to the 
toxicant. MeHgCl induced alterations in the expression of MT, GST, and HSP, all 
of which have been implicated in resistance to the organometal. These data 
show that expression of gst-4 and hsp-4 is induced by a long exposure time of L4 
animals to MeHgCl while expression of mtl-1 and gst-4 is induced by a short 
exposure time of L1 animals to MeHgCl. These results indicate expression of 
 these proteins is upregulated following exposure to MeHgCl. Even though no 
increases in mtls were noted following a chronic exposure at the L4 stage, a lack 
of these proteins conferred increased sensitivity in C. elegans, indicating that 
while mtls are not induced by the toxicant, they are involved in protection and 
detoxification.  
 Interestingly, despite the induction of gst-4 upon exposure to MeHgCl, no 
shift in the lethality dose-response curve was observed of the gst-4 knockout 
strain, indicating that its absence does not increase the sensitivity of the animal 
to the toxicant. One possible explanation for this result is that while gst-4 is 
involved in the response to the toxicant, other mechanisms are able to 
compensate in its absence. C. elegans express nearly 50 GSTs (van Rossum et 
al., 2001), approximately 10 HSPs of the HSP70 family (Heschl and Baillie, 
1989), and 2 MTs (Freedman et al., 1993). Previous work in C. elegans has 
shown that gst-4 is upregulated in response to a variety of stressors, including 
paraquat (Tawe et al., 1998), juglone (Kampkotter et al., 2007; Kahn et al., 
2008), hyperbaric oxygen (Link and Johnson, 2002), progesterone (Custodia et 
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al., 2001), diethylstilbetrol (Reichert and Menzel, 2005), and acrylamide (Tawe et 
al., 1998; Hasegawa et al., 2008); hsp-4 in response to heat, tunicamycin (Calfon 
et al., 2002), and irradiation (Bertucci et al., 2009); and mtl-1 and mtl-2 in 
response to cadmium and heat (Freedman et al., 1993; Swain et al., 2004). 
These proteins are involved in the nematode’s response to the toxicants and may 
be mediating detoxification processes. Our results indicate that some of the 
same mechanisms are involved in detoxification in C. elegans as have been 
identified in other model systems (Sacco et al., 1997; Schlawicke Engstrom et 
al., 2008; Yoshida et al., 2008). 
 MeHg induces the generation of ROS, mediators of MeHg toxicity in glial 
and neuronal cell culture (Sarafian and Verity, 1991; Yee and Choi, 1996). MTs 
are free radical scavengers and are induced in response to oxidative stress 
(Bauman et al., 1991; Maret, 2008) and also in response to MeHg exposure 
(Rising et al., 1995). The role of GSH in ROS elimination has been well-
established and maintenance of GSH levels following MeHg exposure protects 
cells from oxidative injury (Kaur et al., 2006). Our results demonstrate increases 
in gst-4, GSH, hsp-4 and mtl-1, which implicate the induction of oxidative stress 
by MeHg, corroborating results in mammalian systems (Garg and Chang, 2006; 
Reardon, 2007). 
 Most parameters examined after the L1 acute treatment both in these 
studies and in previous studies (Helmcke et al., 2009) demonstrated slight or no 
changes. It is however possible that the 30-minute exposure may be too short to 
induce alterations large enough to be quantified in our assays. Although the 
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investigated proteins may contribute to the resistance of the C. elegans nervous 
system to MeHgCl, further investigation of these mechanisms, including the use 
of knockouts or RNAi can be used to further establish the mechanisms involved. 
 The hormesis phenomenon has been established in many systems upon 
exposure to various stressors. Given the effects of MeHgCl on gst-4, hsp-4, mtl-
1, and mtl-2, we examined whether these proteins play a role in hormesis and 
whether changes in expression levels afford protection to C. elegans. We 
observed that animals with prior early exposure to MeHgCl showed a significant 
increase in resistance to a subsequent exposure to MeHgCl. Although this was 
the first time MeHgCl was shown to have this hormetic effect on C. elegans, this 
phenomenon is not unique to MeHgCl and has been observed when C. elegans 
were exposed to stressors, such as dietary restriction and heat-stress (Cypser et 
al., 2006). The hormesis effect is also not unique to C. elegans and has been 
shown in systems ranging from cells to humans upon exposure to a variety of 
stressors, including Hg and Cd exposure to cells (Damelin et al., 2000), radiation 
exposure to rodents (Zhang et al., 2009), and exercise and caloric restriction to 
humans (Calabrese, 2005; Mattson, 2008b).  
 Our results indicate that adaptation takes place in animals exposed to 
MeHgCl which renders them better-equipped to deal with a second exposure to 
the same stressor. There are many potential explanations and candidate proteins 
responsible for this phenomenon, including the upregulation of proteins involved 
in detoxification, upregulation of proteins involved in excretion or downregulation 
of proteins involved in uptake, only one of which we elucidated here. Further 
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investigation, such as microarray experiments will be valuable for identifying the 
other specific proteins involved, potentially other GSTs or HSPs, in MeHgCl 
resistance, and could perhaps enable humans to more effectively deal with 
poisoning events. 
 Here, we assessed whether MTs, a GST, or a HSP could contribute to the 
hormetic response of C. elegans. Since these proteins are not upregulated prior 
to the second insult of MeHgCl, these data cannot explain the hormetic 
phenotype observed in the lethality experiments. However, expression of gst-
4::GFP increased as the acute exposure concentration of MeHgCl increased 
while chronic exposure conditions remained at baseline. Large increases in gst-
4::GFP fluorescence are consistent with the proposal that GST levels are 
elevated in response to MeHgCl toxicity. However, the involvement of gst-4 in the 
hormetic response remains unclear. While increases in fluorescence were noted 
in groups with increasing initial exposure concentrations when the subsequent 
treatment was 0 mM MeHgCl, this same trend was not observed upon exposure 
to higher chronic concentrations of MeHgCl. This lack of a further increase in 
fluorescence could be attributed to a ceiling effect or an inability to differentiate 
very bright fluorescence. The increase in fluorescence, even at control conditions 
does provide some evidence that gst-4 could play a role in hormesis, since initial 
exposure to increasing MeHgCl concentrations induces an increase in 
fluorescence in subsequent stressful treatment conditions. We also observed 
increases in mtl-1 and mtl-2 expression when animals were preconditioned with 
MeHgCl. These results were inconsistent with our previous observations 
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demonstrating the lack of an increase in fluorescence in these strains upon a 
single chronic exposure to MeHCl. However, as this trend occurred in both 
animals treated under control conditions and animals treated with higher 
concentrations of MeHgCl, we hypothesize that these proteins are not 
responsible for the shift in the lethality dose-response curve upon hormesis. 
 The lack of an increase and the presence of a decrease in fluorescence in 
the other proteins examined (hsp-4, mtl-1, and mtl-2) was surprising, particularly 
given the data outlined earlier in the paper demonstrating some increases in 
fluorescence and sensitivity to knockouts of strains carrying GFP reporters or 
knockouts of these proteins. These data indicate that a mechanism that we did 
not examine plays a significant role in hormesis, and perhaps its involvement in 
this process renders the examined proteins less-important in this response. 
 After observing the involvement of gst-4, we further explored the 
contribution of GSH to the toxicity of MeHgCl. MeHgCl induced an increase in 
GSH and the GSH/GSSG ratio upon acute L1 exposure. Results showed that 
total GSH levels remained unchanged. These results indicate that acute MeHgCl 
increases production of GSH, assisting with the detoxification of MeHgCl. 
Increasing the duration of MeHgCl exposure in C. elegans at L4 to 15 hours 
resulted in a vastly different glutathione profile. At 0.2 mM MeHgCl, the GSH 
levels remained constant while the GSH/GSSG ratio decreased, caused by an 
increase in the amount of GSSG, presumably due to an accumulation of reactive 
oxygen species. At 0.4 mM MeHgCl, GSH, the GSH/GSSG ratio and the total 
glutathione levels all significantly decreased, indicating that GSH is both 
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converted to GSSG due to the presence of reactive oxygen species and excreted 
in a complex with MeHg. Taken with the gst-4::GFP data, these results confirm 
the involvement of glutathione in MeHgCl toxicity in C. elegans. These data 
suggest that the increase in gst-4 successfully catalyzes the conjugation of MeHg 
to GSH, which is then excreted, causing the GSH and total glutathione levels to 
decrease. These data corroborate what has been found in mammalian systems, 
with MeHg being excreted as a complex with glutathione (Hirata and Takahashi, 
1981). Additionally, alterations in the glutathione cycle can cause alterations in 
MeHg metabolism, such as a depletion of GSH leading to a decreased rate of 
conjugation to MeHg and a decrease in MeHg excretion (Schlawicke Engstrom et 
al., 2008). These findings indicate that independent lowering of GSH level would 
sensitize animals to MeHg while increasing GSH level may be protective. Taken 
together, our findings of alterations in GSH, gst-4, mtl-1, and mtl-2 confirm the 
involvement of ROS in MeHgCl toxicity and the ability of these proteins to confer 
resistance as shown by studies in other systems. 
 While previous researchers have shown the toxicity of MeHg and have 
identified some mechanisms involved in detoxification, we furthered their work by 
examining the role of GSH, HSP, and MTs in protection from MeHgCl, 
specifically by examining their role in hormesis. Our work begins to elucidate 
potential mechanisms of MeHgCl toxicity and neuroprotection in C. elegans, 
however, many other pathways are likely involved. Future studies should confirm 
our results based on GFP reporter expression as examined by fluorescence by 
conducting quantitative PCR experiments. To further extend this work, 
 100
experiments should be designed to reveal the pathways responsible for the 
hormetic response. Induction or supplementation of components of these 
pathways could afford a better understanding of resistance to toxicants, stress, or 
aging. Hormesis, in cases where exposure to very low doses may be beneficial 
while the slightest increase could have deleterious effects, needs to be better 
understood. Due to its ease of use and the genetic advantages associated with 
its use, C. elegans, especially with respect to the availability of knockout and 
GFP-tagged strains, is an ideal model for future studies. Techniques such as 
microarray experiments can be used to identify candidate genes involved in 
hormesis, which can be further investigated using the immense genetic 
advantages that the C. elegans model provides. 
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CHAPTER IV 
 
CONCLUSION 
 
Summary 
 MeHg is a toxicant known to induce nervous system damage in humans 
although the mechanisms through which it causes this damage remain poorly 
understood. Since humans are regularly exposed to MeHg through consumption 
of seafood and can be exposed through poisoning events as occurred in 
Minimata Bay and Iraq, an understanding of the molecular mechanisms of MeHg 
toxicity and protection are essential for discovering potential therapeutics. A 
model such as C. elegans, featuring a simple nervous system in an intact 
organism was an ideal model for this research as it could be used as a high 
throughput system to assess death and protection to assist with the discovery of 
molecules involved in MeHg toxicity and protection. 
 Although a number of endpoints we measured indicated a sensitivity of C. 
elegans to MeHg, we were not able to demonstrate alterations in the morphology 
of the nervous system following exposure to MeHg as expected. Due to the lack 
of alterations induced in the nervous system of this model, C. elegans may be a 
poor model for studying MeHg-induced neurotoxicity. However, our model can 
provide valuable insights into the mechanisms of MeHg toxicity and protection of 
this model system and its nervous system. Previous experiments in other 
systems have indicated the involvement of pathways in MeHg toxicity and 
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detoxification. For example, relating to the systems we examined, GSH acts as 
an antioxidant and binds directly to MeHg, facilitating its elimination; MTs can 
also act as antioxidants and can bind to MeHg, sequestering it in the system to 
prevent binding to other targets; and HSPs can reduce or prevent damage 
caused by MeHg by acting as a molecular chaperone to assist with the 
degradation or repair of proteins damaged by MeHg. Our investigations revealed 
alterations in some pathways contributing to MeHg detoxification upon exposure 
to the toxicant which differ depending on the age of the animal treated and the 
duration of the exposure (Figure 1A). In L1 animals treated for 30 minutes, we 
observed increases in gst-4, GSH, and MT expression, implicating the 
involvement of these pathways in detoxification of the toxicant following a short-
duration exposure at a young age (Figure 1B). Following a 15-hour treatment of 
L4 animals, we observed an increase in gst-4 and hsp-4, but no alteration in MT 
expression although MT knockout animals were more sensitive to the toxicant 
under this treatment paradigm. We also observed an increase in GSSG levels 
and a depletion of GSH, indicating that the glutathione system could not 
compensate to protect the older organisms over a long-duration exposure (Figure 
1C). Neither hsp-4 nor MTs played a role in preconditioning, while gst-4 was 
upregulated (Figure 1D). 
 One explanation for the lack of alterations in many parameters including 
altered sensitivity of knockouts and alterations in GFP reporter fluorescence 
intensity upon MeHg exposure in L1 animals treated for 30 minutes may be that 
the exposure duration is too short to induce alterations in protein expression or 
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Figure 1. Model of the molecular mechanisms of MeHg toxicity. MeHg induces 
alterations in the cell by generating ROS and binding directly to Cys groups on 
proteins. These induce a number of downstream effects, including induction of 
HSPs to induce degradation of damaged proteins, MTs to bind free MeHg and 
reduce ROS, and GSH to reverse ROS damage and bind directly to MeHg for 
excretion (A). In L1 animals treated acutely with MeHg, MTs, gst-4, and GSH are 
all upregulated, assisting with MeHg detoxification (B). In L4 animals treated 
chronically with MeHg, levels of hsp-4, gst-4, and GSSG are increased, and GSH 
is depleted (C). In preconditioning, gst-4 is increased. Due to the increase in gst-
4, we suspect alterations in the GSH system, but these have not been assessed 
(D). 
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 nervous system morphology.  Additionally, the Hg levels that were measured in 
these animals were quite low, possibly below the level required to induce 
alteration in levels of the proteins we tested. In young (L1) animals, Hg levels 
were on the order of three times lower than levels in older (L4) animals treated 
under the same conditions. This could occur due to a lack of protective 
mechanisms in young C. elegans, for example their development later in the 
animal’s life cycle, or exposure to the toxicant that induces damage at a critical 
window of development that cannot be repaired early in the animal’s life cycle. 
Despite the low accumulation of Hg in these animals, MeHg displayed higher 
toxicity in these younger animals than in the older animals, indicating that MeHg 
may be deleterious to the developmental processes in the young animal or that 
compensatory mechanisms of MeHg toxicity are not yet established in L1 worms. 
MeHg might induce death via some pathway unrelated to those we examined at 
low concentrations in these young animals, not allowing accumulation of the 
toxicant to levels high enough to induce dramatic alterations in the systems that 
we did examine. 
 The animals treated chronically at the L4 stage do display more of the 
expected effects such as increased expression of hsp-4, GSH depletion, and 
shifts in the lethality curves of mtl-1 and mtl-2 knockout animals, however, these 
alterations did not occur in all of the systems that we examined. The emergence 
of these expected effects may be due to higher accumulation of Hg within the 
animals and a longer duration of exposure to the toxicant. The lack of an effect 
on nervous system morphology may be explained by the fact that the nervous 
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system is already largely in place by the L4 stage, so that exposing animals at 
this time point would not induce developmental disruptions. A lack of alterations 
in some of the other systems we tested may be attributable to differences 
between C. elegans and mammalian models or redundancy within the system. 
Alternate proteins may take over the role of others in knockout models. It is 
possible that a suite of proteins, each having a small alteration in their expression 
level, is induced, with the change in each protein being small and statistically 
undetectable by our methods. 
 While many of the endpoints that we measured, including lifespan, brood 
size, and thrashing behavior, did not reveal a MeHg dose-dependent alteration, 
we did observe alterations in size, development, and pharyngeal pumping rate. 
One explanation for the presence of alterations in these specific endpoints is that 
C. elegans mounts an adaptive response to MeHg by preventing the uptake of 
additional MeHg by reducing pharyngeal pumping rate and stunting growth and 
development until more favorable conditions are encountered. 
 We did not observe obvious alterations in the nervous system of C. 
elegans upon exposure to MeHg. This is potentially due to the presence of novel 
pathways that are able to protect the C. elegans nervous system from the 
toxicant. Our behavioral experiments indicated that there may be some alteration 
in the pharyngeal nervous system upon exposure to MeHg, but our thrashing 
assays indicated that there is not an effect of the toxicant on overall movement of 
the animal. However, we did not directly test neuronal function, and while 
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morphology appeared unaltered, it is possible that the neurons have alterations 
in different parameters such as in signal transduction or neurotransmitter content. 
 In the hormesis model, we noted a potential role of gst-4.  Further 
experiments, such as an experiment with the gst-4 KO would be needed to 
confirm the role of this protein in hormesis since the increase in fluorescence was 
only observed under control conditions. This could be attributed to a ceiling 
effect, or the inability to detect greater increases in fluorescence due to the 
dramatic increase in fluorescence and consequent excessive brightness of these 
animals. Additionally, the Hg levels in animals treated with MeHg under the 
hormesis paradigm are unknown. Prior exposure to MeHg could alter the ability 
of Hg to accumulate within the worm by altering pathways related to uptake, 
including pharyngeal pumping, or excretion, which could lead to a decrease in Hg 
content of the animals previously exposed to MeHg. 
 In our experiments, we noted a dramatic increase in expression of some 
proteins (gst-4 under L4 chronic conditions), more subtle increases in other 
proteins (gst-4 under L1 acute conditions, hsp-4 and mtl-1 under L4 chronic 
conditions), and no increase in other proteins (mtl-2 under L4 chronic conditions, 
mtls and hsp-4 under L1 acute conditions). Although we initially expected to see 
more dramatic increases in expression, our results indicate that in response to 
MeHg, C. elegans is able to upregulate specific proteins. This provides important 
evidence that MeHg is not simply inducing the expression of many proteins 
involved in the stress response, but that it selectively induces upregulation of 
proteins that might be involved explicitly in the protection of the organism from 
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the particular toxicant. Upregulation was less dramatic in young worms, which 
may be due to a smaller effect in these worms, but could also be explained by 
the shorter duration of exposure to the toxicant. In mammalian systems, 
researchers have observed similar effects, such as upregulation of antioxidant 
genes. Additional experiments, such as microarray experiments, have 
demonstrated the specificity of gene up- or down-regulation upon MeHg 
exposure in cellular or mammalian systems (Hwang and Naganuma, 2006; Padhi 
et al., 2008; Glover et al., 2009). 
 The most dramatic molecular alterations that we observed were in the 
glutathione system, pointing to the primary involvement of glutathione in the 
response to and protection from MeHg toxicity. This could blunt the effect of 
MeHg on other secondary systems, leading to a decreased response in the 
presence of glutathione. Without the protection from the glutathione system, 
perhaps the mtls and hsp-4 would play a more prominent role in the 
detoxification of MeHg from the C. elegans system. 
 Though we did reveal these potential mechanisms of protection from 
MeHg, we did not elucidate the mechanism of death from MeHg toxicity in C. 
elegans. Since we did not observe obvious morphological alterations in the 
nervous system, we hypothesize that death is occurring via a mechanism 
unrelated to the nervous system. A decrease in pharyngeal pumping rate was 
observed upon exposure to MeHg. Since this contributes to the ability of the 
worm to eat, lowering or completely ceasing pharyngeal pumping action could 
cause damage to the worm, however, due to the lack of dauer formation of 
 108
animals treated with MeHg, this mechanism of death seems unlikely. MeHg could 
induce necrosis or apoptosis of C. elegans cells essential for life. Mechanisms for 
protecting animals from MeHg insult could also be essential for other functions 
within the worm. When these systems are monopolized by MeHg, they are not 
able to exert their normal function and lead to death of the animal. Further 
experimentation on systems that could lead to MeHg-induced death in C. 
elegans are required to elucidate the mechanism of death. 
 
Future Directions 
 These experiments have laid an excellent foundation for the discovery of 
targets of MeHg toxicity and protection, however, further experimentation will 
confirm and further our results. While we observed no changes in the structure of 
the nervous system, our studies do not address the functioning of the nervous 
system beyond gross behavioral experiments. Further experiments could include 
a more in-depth observation of potential effects of neurotransmitter systems that 
were not quantitatively assessed in these studies, such as assessing animals 
treated with MeHg for resistance to aldicarb, an acyetylcholinesterase inhibitor, 
which could reveal alterations in synaptic transmission (Nonet et al., 1998) or 
behavioral assays aimed at assessing the functioning of specific neuronal 
circuits. Our experiments assessed L1s treated acutely and L4s treated 
chronically. Experiments changing these paradigms, such as treating L1s for a 
longer duration may yield interesting findings regarding the ability of a lower 
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concentration of MeHg to induce alterations in the nervous system of young 
worms treated over a long duration. 
 The lack of a neuronal phenotype is unique when comparing C. elegans to 
mammalian systems and future research should investigate the mechanisms that 
C. elegans employs for neuroprotection. For example, a microarray experiment 
comparing control-treated to MeHg-treated animals would provide valuable 
insights into potential candidate genes that demonstrate altered expression upon 
MeHg exposure that contribute to the protection of the nervous system or to the 
hormetic phenomenon we observed. One candidate to test is skn-1, the C. 
elegans homolog of Nrf2, a protein demonstrated to confer resistance to MeHg in 
cellular and Drosophila models (Rand et al., 2009; Wang et al., 2009). The 
described experiments only examined one hsp and gst. Other candidates, such 
as hsp-16, also shown to be upregulated in a hormesis model (Olsen et al., 
2006) should be examined. Our research indicated that while GSTs, HSPs, and 
MTs may be involved in these processes, it is likely that other mechanisms of 
defense may also play a role. After identification of potential contributing factors, 
this model system could be employed to conduct experiments using knockout or 
overexpression strains. Testing alterations in the response to these strains either 
in the organism or specifically in the nervous system (such as an increased 
sensitivity of knockouts or a decreased sensitivity of overexpression strains) 
would be crucial for determining the involvement of specific proteins in protection 
of C. elegans from MeHg. 
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 Additional experiments should address the contributions of GSTs, HSPs, 
and MTs to MeHg toxicity in C. elegans. For example, quantitative PCR 
experiments should be used to confirm our results based on GFP reporter 
fluorescence. Our experiments only tested the increase in fluorescence or a 
reporter for the genes described. We did not assess protein level nor the activity 
level of these proteins. While a knockout of glutathione is embryonically lethal in 
C. elegans (gcs-1, the rate-limiting enzyme in glutathione synthesis, RNAi 
treatment induces embryonic lethality (WormBase)), experiments using agents 
known to alter glutathione levels could answer questions not only regarding the 
involvement of glutathione in MeHg toxicity, but also those related to the 
involvement of secondary pathways that might be masked by the involvement of 
glutathione in detoxification of MeHg. Although gst-4 does demonstrate 
increased expression upon MeHg exposure, the lack of gst-4 does not change 
the dose-response effect of MeHg on the organism. Knocking out all of the gsts 
could help to reveal the importance of these proteins and the GSH system in 
MeHg protection and detoxification, however, as C. elegans contains 
approximately 50 of these proteins, this work could be difficult and could lead to 
an embryonic lethal strain. 
 An interesting extension of this work would be to determine the role of gst-
4 in MeHg toxicity and whether other gsts or alternate proteins are able to 
compensate for gst-4 loss. Conversely, mtls demonstrated little to no alterations 
in their expression upon MeHg exposure but their lack rendered L4 animals 
treated chronically more sensitivity to the toxicant. One extension of this finding 
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would be to determine how mtls are able to afford protection to MeHg without 
being upregulated and whether there are alterations in MeHg accumulation in mtl 
knockout animals. For example, one such experiment would examine the 
glutathione profile of mtl knockout animals following treatment with MeHg.  
 The ability of MeHg to induce hormesis and the mechanisms involved in 
this process should also be further examined. Future experiments could assess 
the ability of Hg to accumulate in C. elegans preconditioned with MeHg. A 
decrease in the level of Hg in preconditioned animals would help to describe 
mechanisms of detoxification through decreased uptake or increased excretion, 
which contribute to hormesis. Additionally, experiments could be directed toward 
determining whether hormesis is time-dependent, i.e., whether the initial 
exposure must occur during some critical window or whether hormesis can be 
induced by MeHg exposure at any point in the C. elegans life cycle. Further 
investigations into the effects of preconditioning on GSH and GSSG levels as 
well as the ability of MeHg to induce hormesis in gst-4 knockouts will help to 
reveal the mechanisms of this phenomenon.  
 The mechanism of death and the protection of the morphology of the 
nervous system should also be further examined. By examining systems required 
for life in C. elegans but that aren’t involved in endpoints such as lifespan and 
brood size (since no alterations were observed in these parameters), researchers 
can discover the mechanisms of death upon exposure to MeHg. One important 
finding of this research was the decrease in pharyngeal pumping rate, which 
likely led to a developmental delay. One way to test a potential contribution of 
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pharyngeal pumping rate to MeHg toxicity would be to expose animals with 
alterations in pharyngeal pumping rate (such as eat mutants) to MeHg to 
determine whether MeHg acts synergistically with the mutation and causes 
greater death. An important control to consider in these experiments would be to 
determine the Hg content of these animals under various MeHg concentrations 
since they may accumulate MeHg at a decreased rate due to a decrease in 
pumping. Experiments testing the potential contribution of necrosis or apoptosis 
should also be conducted. Mutant animals, for example those with a suppressed 
ability to induce necrotic-like pathways (such as calreticulin mutants (Xu et al., 
2001)) could be used to determine whether necrosis plays an important role in 
MeHg toxicity. If it does play an important role, protection would be afforded in 
such a mutant. Research using markers of necrosis and apoptosis would also be 
valuable since these studies would reveal not only a mechanism of death but 
also in which cells this process may be important. 
 Additional experiments should also examine the sensitivity of C. elegans 
neurons to MeHg. Although we measured Hg content in C. elegans, the specific 
content in the environment of C. elegans neurons was not assessed. Therefore, 
experiments such as C. elegans neuronal cell cultures will be instrumental for 
discovering at which MeHg concentration alterations in C. elegans neurons are 
observed. 
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Implications 
 Our research has a number of implications for toxicology research and 
human health. We demonstrated the usefulness of the C. elegans model system 
in toxicology research. Although it displays high homology with mammalian 
systems, the processes and mechanisms are not always identical in the two 
systems. We demonstrated this in our data revealing that the C. elegans nervous 
system morphology was largely unaffected by MeHg while previous researchers 
had shown major alterations in the architecture of the mammalian nervous 
system upon exposure to the same toxicant. While this could signify an inability 
to use this system as a model for studying MeHg toxicity, or even toxicity 
research in general, we used this to our advantage. Revealing these alterations 
is as important as revealing similarities, as these alterations could provide hints 
and directions for the pursuit of therapies to protect or heal damage caused by 
toxicants. Our experiments demonstrate the advantages of using C. elegans as a 
model for toxicology research, even in cases of divergent responses from 
mammalian systems, such as we found with MeHg toxicity. Follow-up studies 
furthering our research could reveal genes that confer resistance to MeHg and 
could assist in the identification of pharmacological interventions aimed at 
preventing or repairing damage caused by MeHg toxicity. 
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